

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: Decreased Expression of Sprouty2 in the Dorsolateral Prefrontal Cortex in Schizophrenia and Bipolar Disorder: A Correlation with BDNF Expression</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0001784"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0001784" />

    <meta name="citation_title" content="Decreased Expression of Sprouty2 in the Dorsolateral Prefrontal Cortex in Schizophrenia and Bipolar Disorder: A Correlation with BDNF Expression"/>
    <meta itemprop="name" content="Decreased Expression of Sprouty2 in the Dorsolateral Prefrontal Cortex in Schizophrenia and Bipolar Disorder: A Correlation with BDNF Expression"/>

      <meta name="citation_author" content="Anilkumar Pillai"/>
            <meta name="citation_author_institution" content="Department of Psychiatry and Health Behavior, Medical College of Georgia, Medical Research Service Line, Veterans Affairs Medical Center, Augusta, Georgia, United States of America"/>

    <meta name="citation_date" content="2008/3/12"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0001784.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e1784"/>
    <meta name="citation_issue" content="3"/>
    <meta name="citation_volume" content="3"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=Mitochondria, synaptic plasticity, and schizophrenia.; citation_author=D Ben-Shachar; citation_author=D Laifenfeld; citation_journal_title=Int Rev Neurobiol; citation_volume=59; citation_number=1; citation_pages=273-296; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame?; citation_author=SL Eastwood; citation_journal_title=Int Rev Neurobiol; citation_volume=59; citation_number=2; citation_pages=47-72; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Neurodevelopment, neuroplasticity, and new genes for schizophrenia.; citation_author=SE Arnold; citation_author=K Talbot; citation_author=CG Hahn; citation_journal_title=Prog Brain Res; citation_volume=147; citation_number=3; citation_pages=319-345; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Role of neurotrophins in cholinergic-neuron function in the adult and aged CNS.; citation_author=RJ Rylett; citation_author=LR Williams; citation_journal_title=Trends Neurosci; citation_volume=17; citation_number=4; citation_pages=486-490; citation_date=1994; " />
      <meta name="citation_reference" content="citation_title=Reduced size of retinal ganglion cell axons and hypomyelination in mice lacking brain-derived neurotrophic factor.; citation_author=A Cellerino; citation_author=P Carroll; citation_author=H Thoenen; citation_author=YA Barde; citation_journal_title=Mol Cell Neurosci; citation_volume=9; citation_number=5; citation_pages=397-408; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=Plasticity in the developing visual system.; citation_author=T Pizzorusso; citation_author=L Maffei; citation_journal_title=Curr Opin Neurol; citation_volume=9; citation_number=6; citation_pages=122-125; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis.; citation_author=CR Bramham; citation_author=E Messaoudi; citation_journal_title=Prog Neurobiol; citation_volume=76; citation_number=7; citation_pages=99-125; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia.; citation_author=G Shoval; citation_author=A Weizman; citation_journal_title=Eur Neuropsychopharmacol; citation_volume=15; citation_number=8; citation_pages=319-329; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Neurotrophins and schizophrenia.; citation_author=PF Buckley; citation_author=S Mahadik; citation_author=A Pillai; citation_author=A Terry; citation_journal_title=Schizophr Res; citation_volume=94; citation_number=9; citation_pages=1-11; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia.; citation_author=CS Weickert; citation_author=TM Hyde; citation_author=BK Lipska; citation_author=MM Herman; citation_author=DR Weinberger; citation_journal_title=Mol Psychiatry; citation_volume=8; citation_number=10; citation_pages=592-610; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia.; citation_author=CS Weickert; citation_author=DL Ligons; citation_author=T Romanczyk; citation_author=G Ungaro; citation_author=TM Hyde; citation_journal_title=Mol Psychiatry; citation_volume=10; citation_number=11; citation_pages=637-650; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia.; citation_author=T Hashimoto; citation_author=SE Bergen; citation_author=QL Nguyen; citation_author=B Xu; citation_author=LM Monteggia; citation_journal_title=J Neurosci; citation_volume=25; citation_number=12; citation_pages=372-383; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Brain derived neurotrophic factor and neurotrophin-3 in schizophrenic psychoses.; citation_author=T Durany; citation_author=R Michel; citation_author=KW Zochling; citation_author=FF Boissl; citation_author=F Cruz-Sanchez; citation_journal_title=Schizophrenia Res; citation_volume=52; citation_number=13; citation_pages=79-86; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains.; citation_author=S Iritani; citation_author=K Niizato; citation_author=H Hawa; citation_journal_title=Progress in Neuro-Psychopharmacology and Biological Psychiatry; citation_volume=27; citation_number=14; citation_pages=801-807; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients.; citation_author=M Takahashi; citation_author=O Shirakawa; citation_author=K Toyooka; citation_author=N Kitamura; citation_author=T Hashimoto; citation_journal_title=Mol Psychiatry; citation_volume=5; citation_number=15; citation_pages=293-300; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients.; citation_author=K Toyooka; citation_author=K Asama; citation_author=Y Watanabe; citation_author=T Muratake; citation_author=M Takahashi; citation_journal_title=Psychiatry Res; citation_volume=110; citation_number=16; citation_pages=249-257; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.; citation_author=YL Tan; citation_author=DF Zhou; citation_author=XY Zhang; citation_journal_title=Schizophr Res; citation_volume=74; citation_number=17; citation_pages=263-270; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics.; citation_author=RW Grillo; citation_author=GL Ottoni; citation_author=R Leke; citation_author=DO Souza; citation_author=LV Portela; citation_journal_title=J Psychiatr Res; citation_volume=4; citation_number=18; citation_pages=31-35; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls.; citation_author=E Shimizu; citation_author=K Hashimoto; citation_author=H Watanabe; citation_author=N Komatsu; citation_author=N Okamura; citation_journal_title=Neurosci Lett; citation_volume=351; citation_number=19; citation_pages=111-114; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse.; citation_author=MC Jockers-Scherübl; citation_author=H Danker-Hopfe; citation_author=R Mahlberg; citation_author=F Selig; citation_author=J Rentzsch; citation_journal_title=Neurosci Lett; citation_volume=371; citation_number=20; citation_pages=79-83; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Brain derived neurotrophic factor in first-episode psychosis.; citation_author=PF Buckley; citation_author=A Pillai; citation_author=D Evans; citation_author=E Stirewalt; citation_author=S Mahadik; citation_journal_title=Schizophr Res; citation_volume=91; citation_number=21; citation_pages=1-5; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyl transferase in rat brain regions.; citation_author=F Angelucci; citation_author=L Aloe; citation_author=SH Gruber; citation_author=M Fiore; citation_author=AA Mathe; citation_journal_title=Int J Neuropsychopharmacol; citation_volume=3; citation_number=22; citation_pages=13-25; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus.; citation_author=A Pillai; citation_author=AV Terry; citation_author=SP Mahadik; citation_journal_title=Schizophr Res; citation_volume=82; citation_number=23; citation_pages=95-106; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling.; citation_author=JM Mason; citation_author=DJ Morrison; citation_author=MA Basson; citation_author=JD Licht; citation_journal_title=Trends Cell Biol; citation_volume=16; citation_number=24; citation_pages=45-54; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Modulation of signalling by Sprouty: a developing story.; citation_author=HJ Kim; citation_author=D Bar-Sagi; citation_journal_title=Nat Rev Mol Cell Biol; citation_volume=5; citation_number=25; citation_pages=441-450; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Sprouty2 inhibits BDNF-induced signaling and modulates neuronal differentiation and survival.; citation_author=I Gross; citation_author=O Armant; citation_author=S Benosman; citation_author=JL de Aguilar; citation_author=JN Freund; citation_journal_title=Cell Death Differ; citation_volume=14; citation_number=26; citation_pages=1802-1812; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia.; citation_author=WE Bunney; citation_author=BG Bunney; citation_journal_title=Brain Res Brain Res Rev; citation_volume=31; citation_number=27; citation_pages=138-146; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Increased expression in dorsolateral prefrontal cortex of CAPON in schizophrenia and bipolar disorder.; citation_author=B Xu; citation_author=N Wratten; citation_author=EI Charych; citation_author=S Buyske; citation_author=BL Firestein; citation_journal_title=PLoS Med; citation_volume=2; citation_number=28; citation_pages=e263; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Tryptophan hydroxylase 2 gene expression and promoter polymorphisms in bipolar disorder and schizophrenia.; citation_author=V De Luca; citation_author=O Likhodi; citation_author=HH Van Tol; citation_author=JL Kennedy; citation_author=AH Wong; citation_journal_title=Psychopharmacology (Berl); citation_volume=183; citation_number=29; citation_pages=378-382; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder.; citation_author=HT Mueller; citation_author=JH Meador-Woodruff; citation_journal_title=Schizophr Res; citation_volume=71; citation_number=30; citation_pages=361-370; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation.; citation_author=I Gross; citation_author=B Bassit; citation_author=M Benezra; citation_author=JD Licht; citation_journal_title=J Biol Chem; citation_volume=276; citation_number=31; citation_pages=46460-46468; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Mammalian sprouty-1 and -2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells.; citation_author=MA Impagnatiello; citation_author=S Weitzer; citation_author=G Gannon; citation_author=A Compagni; citation_author=M Cotten; citation_journal_title=J Cell Biol; citation_volume=152; citation_number=32; citation_pages=1087-1098; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activation.; citation_author=A Sasaki; citation_author=T Taketomi; citation_author=T Wakioka; citation_author=R Kato; citation_author=A Yoshimura; citation_journal_title=J Biol Chem; citation_volume=276; citation_number=33; citation_pages=36804-36808; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation.; citation_author=J Xing; citation_author=JM Kornhauser; citation_author=Z Xia; citation_author=EA Thiele; citation_author=ME Greenberg; citation_journal_title=Mol Cell Biol; citation_volume=18; citation_number=34; citation_pages=1946-1955; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Sp1 phosphorylation by Erk 2 stimulates DNA binding.; citation_author=JL Merchant; citation_author=M Du; citation_author=A Todisco; citation_journal_title=Biochem Biophys Res Commun; citation_volume=254; citation_number=35; citation_pages=454-461; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Caspase-3 activation in rat frontal cortex following treatment with typical and atypical antipsychotics.; citation_author=LF Jarskog; citation_author=JH Gilmore; citation_author=LA Glantz; citation_author=KL Gable; citation_author=TT German; citation_journal_title=Neuropsychopharmacology; citation_volume=32; citation_number=36; citation_pages=95-102; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Erythropoietin Prevents Haloperidol Treatment-Induced Neuronal Apoptosis through Regulation of BDNF.; citation_author=A Pillai; citation_author=KM Dhandapani; citation_author=BA Pillai; citation_author=AV Terry; citation_author=SP Mahadik; citation_journal_title=Neuropsychopharmacology Sep 5; citation_number=37; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Treatment with olanzapine increases cell proliferation in the subventricular zone and prefrontal cortex.; citation_author=W Green; citation_author=P Patil; citation_author=CA Marsden; citation_author=GW Bennett; citation_author=PM Wigmore; citation_journal_title=Brain Res; citation_volume=1070; citation_number=38; citation_pages=242-245; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat.; citation_author=M Kodama; citation_author=T Fujioka; citation_author=RS Duman; citation_journal_title=Biol Psychiatry; citation_volume=56; citation_number=39; citation_pages=570-580; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells.; citation_author=W Ding; citation_author=W Shi; citation_author=S Bellusci; citation_author=J Groffen; citation_author=N Heisterkamp; citation_journal_title=J Cell Physiol; citation_volume=212; citation_number=40; citation_pages=796-806; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Signal transduction and genes-to-behaviors pathways in psychiatric diseases.; citation_author=HK Manji; citation_author=II Gottesman; citation_author=TD Gould; citation_journal_title=Sci STKE; citation_volume=2003; citation_number=41; citation_pages=pe49; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Roles of serine/threonine phosphatases in hippocampal synaptic plasticity.; citation_author=DG Winder; citation_author=JD Sweatt; citation_journal_title=Nat Rev Neurosci; citation_volume=2; citation_number=42; citation_pages=461-474; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Neuregulin 1 and susceptibility to schizophrenia.; citation_author=H Stefansson; citation_author=E Sigurdsson; citation_author=V Steinthorsdottir; citation_author=S Bjornsdottir; citation_author=T Sigmundsson; citation_journal_title=Am J Hum Genet.; citation_volume=71; citation_number=43; citation_pages=877-892; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia.; citation_author=G Corfas; citation_author=K Roy; citation_author=JD Buxbaum; citation_journal_title=Nat Neurosci; citation_volume=7; citation_number=44; citation_pages=575-580; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Genome-wide expression analysis reveals dysregulation of myelination-relatedgenes in chronic schizophrenia.; citation_author=Y Hakak; citation_author=JR Walker; citation_author=C Li; citation_author=WH Wong; citation_author=KL Davis; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=98; citation_number=45; citation_pages=4746-4751; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Axonal neuregulin-1 regulates myelin sheath thickness.; citation_author=GV Michailov; citation_author=MW Sereda; citation_author=BG Brinkmann; citation_author=TM Fischer; citation_author=B Haug; citation_journal_title=Science; citation_volume=304; citation_number=46; citation_pages=700-703; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=White matter changes in schizophrenia: evidence for myelin-related dysfunction.; citation_author=KL Davis; citation_author=DG Stewart; citation_author=JI Friedman; citation_author=M Buchsbaum; citation_author=PD Harvey; citation_journal_title=Arch Gen Psychiatry; citation_volume=60; citation_number=47; citation_pages=443-456; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients.; citation_author=T Futamura; citation_author=K Toyooka; citation_author=S Iritani; citation_author=K Niizato; citation_author=R Nakamura; citation_journal_title=Mol Psychiatry; citation_volume=7; citation_number=48; citation_pages=673-682; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=No changes in serum epidermal growth factor levels in patients with schizophrenia.; citation_author=K Hashimoto; citation_author=E Shimizu; citation_author=N Komatsu; citation_author=H Watanabe; citation_author=N Shinoda; citation_journal_title=Psychiatry Res; citation_volume=135; citation_number=49; citation_pages=257-260; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling.; citation_author=R Hashimoto; citation_author=T Numakawa; citation_author=T Ohnishi; citation_author=E Kumamaru; citation_author=Y Yagasaki; citation_journal_title=Hum Mol Genet; citation_volume=15; citation_number=50; citation_pages=3024-3033; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Cell signaling by receptor tyrosine kinases.; citation_author=J Schlessinger; citation_journal_title=Cell; citation_volume=103; citation_number=51; citation_pages=211-225; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Mitogen-activated protein kinases in synaptic plasticity and memory.; citation_author=JD Sweatt; citation_journal_title=Curr Opin Neurobiol; citation_volume=14; citation_number=52; citation_pages=311-317; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf.; citation_author=P Yusoff; citation_author=DH Lao; citation_author=SH Ong; citation_author=ES Wong; citation_author=J Lim; citation_journal_title=J Biol Chem; citation_volume=277; citation_number=53; citation_pages=3195-3201; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=mSprouty2 inhibits FGF10-activated MAP kinase by differentially binding to upstream target proteins.; citation_author=D Tefft; citation_author=M Lee; citation_author=S Smith; citation_author=DL Crowe; citation_author=S Bellusci; citation_journal_title=Am J Physiol Lung Cell Mol Physiol.; citation_volume=283; citation_number=54; citation_pages=L700-706; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling.; citation_author=ES Wong; citation_author=CW Fong; citation_author=J Lim; citation_author=P Yusoff; citation_author=BC Low; citation_journal_title=EMBO J; citation_volume=21; citation_number=55; citation_pages=4796-4808; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=The role of the extracellular signal-regulated kinase pathway in cerebellar abnormalities in schizophrenia.; citation_author=SV Kyosseva; citation_journal_title=Cerebellum; citation_volume=3; citation_number=56; citation_pages=94-99; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Clozapine and the mitogen-activated protein kinase signal transduction pathway: implications for antipsychotic actions.; citation_author=JL Browning; citation_author=T Patel; citation_author=PC Brandt; citation_author=KA Young; citation_author=LA Holcomb; citation_journal_title=Biol Psychiatry; citation_volume=57; citation_number=57; citation_pages=617-623; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Phosphorylation of ERK and CREB in cultured hippocampal neurons after haloperidol and risperidone administration.; citation_author=BH Yang; citation_author=H Son; citation_author=SH Kim; citation_author=JH Nam; citation_author=JH Choi; citation_journal_title=Psychiatry Clin Neurosci; citation_volume=58; citation_number=58; citation_pages=262-267; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum.; citation_author=L Pozzi; citation_author=K Håkansson; citation_author=A Usiello; citation_author=A Borgkvist; citation_author=M Lindskog; citation_journal_title=J Neurochem; citation_volume=86; citation_number=59; citation_pages=451-459; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Risk factors and confounders in the geographical clustering of schizophrenia.; citation_author=EF Torrey; citation_author=PB Mortensen; citation_author=CB Pedersen; citation_author=J Wohlfahrt; citation_author=M Melbye; citation_journal_title=Schizophr Res; citation_volume=49; citation_number=60; citation_pages=295-299; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Effects of antipsychotics on cognitive behavior in rats using the delayed non-match to position paradigm.; citation_author=M Didriksen; citation_journal_title=Eur J Pharmacol; citation_volume=28; citation_number=61; citation_pages=241-250; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, a1-adrenergic and muscarinic receptors in vivo in rats.; citation_author=FP Bymaster; citation_author=SK Hemrick-Luecke; citation_author=KW Perry; citation_author=RW Fuller; citation_journal_title=Psychopharmacology (Berl.); citation_volume=124; citation_number=62; citation_pages=87-94; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Differential effect of antipsychotics on place navigation of rats in Morris water maze. A comparative study between novel and reference antipsychotics.; citation_author=T Skarsfeldt; citation_journal_title=Psychopharmacology (Berl.); citation_volume=124; citation_number=63; citation_pages=126-133; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Mechanisms of action of atypical antipsychotic drugs: a critical analysis.; citation_author=BJ Kinon; citation_author=JA Lieberman; citation_journal_title=Psychopharmacology (Berl); citation_volume=124; citation_number=64; citation_pages=2-34; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Differential effects of haloperidol, risperidone, and clozapine exposure on cholinergic markers and spatial learning performance in rats.; citation_author=AV Terry; citation_author=WD Hill; citation_author=V Parikh; citation_author=JL Waller; citation_author=DR Evans; citation_journal_title=Neuropsychopharmacology; citation_volume=28; citation_number=65; citation_pages=300-309; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Differential effects of chronic haloperidol and olanzapine exposure on brain cholinergic markers and spatial learning in rats.; citation_author=AV Terry; citation_author=WD Hill; citation_author=V Parikh; citation_author=DR Evans; citation_author=JL Waller; citation_journal_title=Psychopharmacology (Berl); citation_volume=164; citation_number=66; citation_pages=360-368; citation_date=2002; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001784" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="Decreased Expression of Sprouty2 in the Dorsolateral Prefrontal Cortex in Schizophrenia and Bipolar Disorder: A Correlation with BDNF Expression"/>
    <meta name="twitter:description" content="BackgroundCurrent theories on the pathophysiology of schizophrenia suggest altered brain plasticity such as decreased neural proliferation and migration, delayed myelination, and abnormal synaptic modeling, in the brain of subjects with schizophrenia. Though functional alterations in BDNF, which plays important role in neuroplasticity, are implicated in many abnormalities found in schizophrenia, the regulatory mechanism(s) involved in the abnormal signaling of BDNF in schizophrenia is not clear. The present study investigated whether Sprouty2, a regulator of growth factor signaling, is abnormally expressed in schizophrenia, and is associated with the changes in BDNF mRNA in this disorder. The potential effect of antipsychotic drugs on Sprouty2 expression was tested in adult rats.Methods and FindingsSprouty2 and BDNF gene expression were analyzed in dorsolateral prefrontal cortex samples from the Stanley Array Collection. Quantitative real-time PCR analysis of RNA in 100 individuals (35 with schizophrenia, 31 with bipolar disorder, and 34 psychiatrically normal controls) showed significantly decreased expression of Sprouty2 and BDNF in both schizophrenia and bipolar disorder. Moreover, a significant correlation between these two genes existed in control, schizophrenia and bipolar subjects. Long-term treatment with antipsychotic drugs, haloperidol and olanzapine, showed differential effects on both Sprouty2 and BDNF mRNA and protein levels in the frontal cortex of rats.ConclusionThese findings demonstrating decreased expression of Sprouty2 associated with changes in BDNF, suggest the possibility that these decreases are secondary to treatment rather than to factors that are significant in the disease process of either schizophrenia and/or bipolar disorder. Further exploration of Sprouty2-related signal transduction pathways may be helpful to design novel treatment strategies for these disorders."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0001784.g003"/>

  <meta property="og:title" content="Decreased Expression of Sprouty2 in the Dorsolateral Prefrontal Cortex in Schizophrenia and Bipolar Disorder: A Correlation with BDNF Expression" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001784" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=956'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=9499'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=625&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0001784">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001784" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001784&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    Decreased Expression of Sprouty2 in the Dorsolateral Prefrontal Cortex in Schizophrenia and Bipolar Disorder: A Correlation with BDNF Expression
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Anilkumar Pillai
              <span class="corresponding">mail</span>
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">* E-mail:</span> <a href="mailto:apillai@mail.mcg.edu">apillai@mail.mcg.edu</a></p>

                <p>Affiliation:
                  Department of Psychiatry and Health Behavior, Medical College of Georgia, Medical Research Service Line, Veterans Affairs Medical Center, Augusta, Georgia, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: March 12, 2008</li>
    <li>DOI: 10.1371/journal.pone.0001784</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0001784" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0001784" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001784" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0001784" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0001784-t001" data-doi="info:doi/10.1371/journal.pone.0001784" data-uri="info:doi/10.1371/journal.pone.0001784.t001" title="Table 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.t001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001784-t002" data-doi="info:doi/10.1371/journal.pone.0001784" data-uri="info:doi/10.1371/journal.pone.0001784.t002" title="Table 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.t002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001784-g001" data-doi="info:doi/10.1371/journal.pone.0001784" data-uri="info:doi/10.1371/journal.pone.0001784.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001784-t003" data-doi="info:doi/10.1371/journal.pone.0001784" data-uri="info:doi/10.1371/journal.pone.0001784.t003" title="Table 3">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.t003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001784-g002" data-doi="info:doi/10.1371/journal.pone.0001784" data-uri="info:doi/10.1371/journal.pone.0001784.g002" title="Figure 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.g002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001784-g003" data-doi="info:doi/10.1371/journal.pone.0001784" data-uri="info:doi/10.1371/journal.pone.0001784.g003" title="Figure 3">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.g003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001784-t004" data-doi="info:doi/10.1371/journal.pone.0001784" data-uri="info:doi/10.1371/journal.pone.0001784.t004" title="Table 4">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.t004&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001784-t005" data-doi="info:doi/10.1371/journal.pone.0001784" data-uri="info:doi/10.1371/journal.pone.0001784.t005" title="Table 5">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.t005&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001784">Reader Comments (2)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0001784" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2>
<h3>Background</h3>
<a id="article1.front1.article-meta1.abstract1.sec1.p1" name="article1.front1.article-meta1.abstract1.sec1.p1"></a><p>Current theories on the pathophysiology of schizophrenia suggest altered brain plasticity such as decreased neural proliferation and migration, delayed myelination, and abnormal synaptic modeling, in the brain of subjects with schizophrenia. Though functional alterations in BDNF, which plays important role in neuroplasticity, are implicated in many abnormalities found in schizophrenia, the regulatory mechanism(s) involved in the abnormal signaling of BDNF in schizophrenia is not clear. The present study investigated whether Sprouty2, a regulator of growth factor signaling, is abnormally expressed in schizophrenia, and is associated with the changes in BDNF mRNA in this disorder. The potential effect of antipsychotic drugs on Sprouty2 expression was tested in adult rats.</p>


<h3>Methods and Findings</h3>
<a id="article1.front1.article-meta1.abstract1.sec2.p1" name="article1.front1.article-meta1.abstract1.sec2.p1"></a><p>Sprouty2 and BDNF gene expression were analyzed in dorsolateral prefrontal cortex samples from the Stanley Array Collection. Quantitative real-time PCR analysis of RNA in 100 individuals (35 with schizophrenia, 31 with bipolar disorder, and 34 psychiatrically normal controls) showed significantly decreased expression of Sprouty2 and BDNF in both schizophrenia and bipolar disorder. Moreover, a significant correlation between these two genes existed in control, schizophrenia and bipolar subjects. Long-term treatment with antipsychotic drugs, haloperidol and olanzapine, showed differential effects on both Sprouty2 and BDNF mRNA and protein levels in the frontal cortex of rats.</p>


<h3>Conclusion</h3>
<a id="article1.front1.article-meta1.abstract1.sec3.p1" name="article1.front1.article-meta1.abstract1.sec3.p1"></a><p>These findings demonstrating decreased expression of Sprouty2 associated with changes in BDNF, suggest the possibility that these decreases are secondary to treatment rather than to factors that are significant in the disease process of either schizophrenia and/or bipolar disorder. Further exploration of Sprouty2-related signal transduction pathways may be helpful to design novel treatment strategies for these disorders.</p>

</div>


<div class="articleinfo"><p><strong>Citation: </strong>Pillai A (2008) Decreased Expression of Sprouty2 in the Dorsolateral Prefrontal Cortex in Schizophrenia and Bipolar Disorder: A Correlation with BDNF Expression. PLoS ONE 3(3):
          e1784.
            doi:10.1371/journal.pone.0001784</p><p><strong>Academic Editor: </strong>Kenji Hashimoto, Chiba University, Japan</p><p><strong>Received:</strong> December 10, 2007; <strong>Accepted:</strong> February 11, 2008; <strong>Published:</strong> March 12, 2008</p><p><strong>Copyright:</strong> © 2008 Pillai. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>The author has no support or funding to report.</p><p><strong>Competing interests:</strong> The author has declared that no competing interests exist.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>Abnormal neurodevelopment (decreased neural proliferation and migration, delayed myelination, abnormal synaptic modeling) and subsequent enhanced vulnerability to untreated illness are implicated in the pathophysiology of schizophrenia <a href="#pone.0001784-BenShachar1">[1]</a>–<a href="#pone.0001784-Arnold1">[3]</a>. Neurotrophic factors exert important actions on the development, maintenance, and function of the peripheral and central nervous system <a href="#pone.0001784-Rylett1">[4]</a>–<a href="#pone.0001784-Bramham1">[7]</a>. For example, deficits in brain derived neurotrophic factor (BDNF) signaling are implicated in many abnormalities found in schizophrenia <a href="#pone.0001784-Shoval1">[8]</a>–<a href="#pone.0001784-Buckley1">[9]</a>. Postmortem studies showed changes in BDNF as well as its receptor, TrkB expression in different brain areas of subjects with schizophrenia <a href="#pone.0001784-Weickert1">[10]</a>–<a href="#pone.0001784-Takahashi1">[15]</a>. Although several studies indicated altered serum BDNF levels in subjects with schizophrenia <a href="#pone.0001784-Toyooka1">[16]</a>–<a href="#pone.0001784-Grillo1">[18]</a>, some other studies failed to find any difference in serum BDNF levels between drug-naïve schizophrenia and control subjects <a href="#pone.0001784-Shimizu1">[19]</a>–<a href="#pone.0001784-JockersScherbl1">[20]</a>. This discrepancy may be due to factors such as biological heterogeneity of the subjects, duration of illness or the antipsychotic medications. More recently, we found a significant reduction in plasma BDNF levels in subjects with first-episode psychosis in comparison with normal healthy controls, and plasma BDNF levels negatively correlated with positive symptom scores at base line <a href="#pone.0001784-Buckley2">[21]</a>. In addition to the clinical observations, pre-clinical studies showed that antipsychotic drugs, the primary choice of treatment for schizophrenia, exert their beneficial effects through growth factor-mediated signaling pathways <a href="#pone.0001784-Angelucci1">[22]</a>–<a href="#pone.0001784-Pillai1">[23]</a>; however, the regulatory mechanism(s) involved in the abnormal signaling of BDNF in schizophrenia is not clear.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>Recent studies indicate the role for Sprouty (Spry) proteins in growth factor signaling <a href="#pone.0001784-Mason1">[24]</a>. Sprouty was first identified in Drosophila and shares a high degree of evolutionary sequence homology in the C-terminus, although mammalian Spry differs from Drosophilia Spry within the N-terminus. Growth factors, including BDNF, induce Sprouty2 (Spry2, a member of sprouty family) expression at the transcriptional level and phosphorylate Spry2 on critical tyrosine residues, suggesting regulation at the transcriptional and the post-translational level <a href="#pone.0001784-Mason1">[24]</a>–<a href="#pone.0001784-Kim1">[25]</a>. Growth factor-mediated receptor-tyrosine kinase (RTK) activation leads to the phospholipid-dependent translocation of Spry2 to plasma membrane, where it binds to various signaling molecules such as Grb-2 <a href="#pone.0001784-Mason1">[24]</a>. Although Spry proteins inhibit RTK signaling induced by many growth factors, including BDNF, EGF-mediated extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) signaling is augmented in a cell-type dependent manner <a href="#pone.0001784-Kim1">[25]</a>. <em>In vitro</em> studies showed that overexpression of Spry proteins antagonizes proliferation, migration and differentiation in response to various growth factors <a href="#pone.0001784-Mason1">[24]</a>–<a href="#pone.0001784-Kim1">[25]</a>. In addition, a recent study showed that Spry2 was involved in the development of the CNS by inhibiting both neuronal differentiation and survival through a negative-feedback loop that downregulates BDNF-mediated signaling pathways <a href="#pone.0001784-Gross1">[26]</a>.</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3"></a><p>Considering neurotrophin involvement in the neuropathogenesis of schizophrenia, the possible role of Spry2, a prototypical member of the sprouty family, was investigated in schizophrenia. The expression of BDNF and Spry2 was examined by quantitative real-time PCR (qRT-PCR) in the Stanley Array Collection, derived from dorsolateral prefrontal cortex (DLPFC) of individuals with schizophrenia, bipolar disorder, or psychiatrically normal controls. The study also examined whether the changes in Spry2 mRNA correlated with the changes in BDNF mRNA; changes which may influence the pathophysiology and pharmacological treatment of schizophrenic patients.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Results"></a><h3>Results</h3>
<h4>Sprouty2 expression is decreased in schizophrenia and bipolar disorder, and correlates with BDNF expression</h4>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1"></a><p>Reverse-transcription real-time PCR was used for the determination of mRNA expression levels of Spry2 and BDNF for the postmortem samples. As shown in <a href="#pone-0001784-t001">Table 1</a>, no significant correlation was found between the mRNA expression of either Spry2 or BDNF and the confounding variables, such as age at death, PMI, brain pH, brain weight, refrigeration interval, gender, hemisphere, smoking status at time of death, age of onset, duration of illness, lifetime alcohol use, or lifetime substance abuse. Furthermore, there was no effect of suicide or cardiac death on the mRNA expression of Spry2 or BDNF (data not shown).</p>
<div class="figure" id="pone-0001784-t001"><div class="img"><a name="pone-0001784-t001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.t001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001784" data-uri="info:doi/10.1371/journal.pone.0001784.t001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.t001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.t001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.t001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.t001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.t001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001784.t001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.t001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.t001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001784.t001.TIF"></span>)
                </a></li></ul></div><p><strong>Table 1.  <span>Correlations between BDNF or sprouty2 mRNA levels and confounding variables</span></strong></p><span>doi:10.1371/journal.pone.0001784.t001</span></div><a id="article1.body1.sec2.sec1.p2" name="article1.body1.sec2.sec1.p2"></a><p>Next, the possible relationship between the effect of antipsychotic medication and the mRNA expression of Spry2 or BDNF was examined. The diagnosis status table obtained from Stanley Foundation on the patients and control subjects indicated that all schizophrenia patients were treated with antipsychotic drug(s) at some point during their disease condition. In contrast, a significant number of patients in bipolar disorder group did not previously receive (n = 12 of 31) antipsychotic medications. No significant correlation was found between antipsychotic use at time of death and Spry2 or BDNF mRNA expression in bipolar patients (<a href="#pone-0001784-t002">Table 2</a>). To understand further the effect of antipsychotic medication on Spry2 and BDNF, the mRNA levels of spry2 and BDNF were examined in antipsychotic-naive patients with bipolar disorder. Spry2 expression was significantly low (p = 0.037) in antipsychotic-naive patients with bipolar disorder (n = 12) compared to control subjects. Although mean BDNF mRNA levels were decreased by 36% in antipsychotic-naive patients with bipolar disorder, this decrease did not reach statistical significance (p = 0.052). As indicated in <a href="#pone-0001784-t002">Table 2</a>, no significant correlations were found between levels of lifetime antipsychotic exposure and expression of either Spry2 or BDNF in schizophrenia group.</p>
<div class="figure" id="pone-0001784-t002"><div class="img"><a name="pone-0001784-t002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.t002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001784" data-uri="info:doi/10.1371/journal.pone.0001784.t002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.t002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.t002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.t002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.t002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.t002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001784.t002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.t002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.t002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001784.t002.TIF"></span>)
                </a></li></ul></div><p><strong>Table 2.  <span>Effect of antipsychotic treatment on BDNF and sprouty2 mRNA expression</span></strong></p><span>doi:10.1371/journal.pone.0001784.t002</span></div><a id="article1.body1.sec2.sec1.p3" name="article1.body1.sec2.sec1.p3"></a><p>A significant reduction in mean Spry2 mRNA levels was observed in the schizophrenia (33%; p = 0.0098) and bipolar groups (46%; p = 0.003) compared to the control group (<a href="#pone-0001784-g001">Figure 1</a>). Similarly, mean BDNF mRNA levels were significantly reduced in schizophrenia group (34%; p = 0.0027) and bipolar group (40%; p = 0.003) as compared to the control group (<a href="#pone-0001784-g002">Figure 2</a>). To study the relationship between Spry2 and BDNF, Pearson's correlation was performed in schizophrenia group, bipolar group and control group (<a href="#pone-0001784-t003">Table 3</a>). Significant high correlation between Spry2 and BDNF mRNA expression levels was found in schizophrenia group (p = 0.01), bipolar group (p = 0.02) and control group (p = 0.016).</p>
<div class="figure" id="pone-0001784-g001"><div class="img"><a name="pone-0001784-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001784" data-uri="info:doi/10.1371/journal.pone.0001784.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001784.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001784.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1.  <span>Normalized Sprouty2 mRNA expression in schizophrenia, bipolar and control subjects.</span></strong></p><a id="article1.body1.sec2.sec1.fig1.caption1.p1" name="article1.body1.sec2.sec1.fig1.caption1.p1"></a><p>Values are expressed as mean±SEM. The number of individuals per sample is indicated within each bar. Sprouty2 expression is significantly low in schizophrenia and bipolar subjects as compared to control subjects. Level of significance as compared to control subjects is shown above each bar.</p>
<span>doi:10.1371/journal.pone.0001784.g001</span></div><div class="figure" id="pone-0001784-t003"><div class="img"><a name="pone-0001784-t003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.t003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001784" data-uri="info:doi/10.1371/journal.pone.0001784.t003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.t003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.t003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.t003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.t003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.t003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001784.t003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.t003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.t003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001784.t003.TIF"></span>)
                </a></li></ul></div><p><strong>Table 3.  <span>Correlation between BDNF and sprouty2 mRNA levels</span></strong></p><span>doi:10.1371/journal.pone.0001784.t003</span></div>

<h4>Antipsychotic drugs modulate BDNF and Sprouty2 expression in rat frontal cortex</h4>
<a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1"></a><p>In order to test the potential effect of antipsychotic medication, we evaluated mRNA as well as protein levels of BDNF and Spry2 in the frontal cortex of rats treated with haloperidol and olanzapine. Haloperidol treated rats showed significant reduction in mRNA (p = 0.03) as well as protein (p = 0.019) levels of BDNF, where as olanzapine treated rats showed significant increase in mRNA (p = 0.023) as well as protein (p = 0.045) levels of BDNF as compared to vehicle-treated rats (<a href="#pone-0001784-g003">Figure 3</a>). Interestingly, significant increase in Spry2 mRNA (p = 0.027) and protein (p = 0.02) expression was found in the frontal cortex of haloperidol-treated rats whereas olanzapine-treated rats showed significant decrease in Spry2 mRNA (p = 0.018) and protein (p = 0.041) expression as compared to vehicle-treated rats.</p>
<div class="figure" id="pone-0001784-g002"><div class="img"><a name="pone-0001784-g002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.g002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001784" data-uri="info:doi/10.1371/journal.pone.0001784.g002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.g002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.g002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.g002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.g002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.g002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001784.g002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.g002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.g002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001784.g002.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 2.  <span>Normalized BDNF mRNA expression in schizophrenia, bipolar and control subjects.</span></strong></p><a id="article1.body1.sec2.sec2.fig1.caption1.p1" name="article1.body1.sec2.sec2.fig1.caption1.p1"></a><p>Values are expressed as mean±SEM. The number of individuals per sample is indicated within each bar. BDNF expression is significantly low in schizophrenia and bipolar subjects as compared to control subjects. Level of significance as compared to control subjects is shown above each bar.</p>
<span>doi:10.1371/journal.pone.0001784.g002</span></div><div class="figure" id="pone-0001784-g003"><div class="img"><a name="pone-0001784-g003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.g003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001784" data-uri="info:doi/10.1371/journal.pone.0001784.g003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.g003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.g003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.g003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.g003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.g003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001784.g003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.g003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.g003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001784.g003.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 3.  <span>BDNF and Sprouty2 expression in the frontal cortex of rats treated with haloperidol or olanzapine.</span></strong></p><a id="article1.body1.sec2.sec2.fig2.caption1.p1" name="article1.body1.sec2.sec2.fig2.caption1.p1"></a><p>Adult rats were treated with haloperidol (2 mg/kg) or olanzapine (10 mg/kg) through drinking water for 45 days, and (A) protein and (B) mRNA levels of BDNF and Sprouty2 in frontal cortex were estimated after the treatment. BDNF protein levels were measured by ELISA and Sprouty2 proteins levels were estimated by Western blot analysis. mRNA levels of both BDNF and Sprouty2 were estimated by qRT-PCR analysis. Open bars represent haloperidol-treated rats whereas filled bars represent olanzapine-treated rats. Values are expressed as fold change relative to vehicle-treated rats. *p&lt;0.05, n = 10–12 per group.</p>
<span>doi:10.1371/journal.pone.0001784.g003</span></div>
</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Discussion"></a><h3>Discussion</h3><a id="article1.body1.sec3.p1" name="article1.body1.sec3.p1"></a><p>The present study for the first time shows that the expression of Spry2, a key regulator of growth factor signaling, is altered in schizophrenia and bipolar disorder compared with normal controls. The key findings from the present study are: First, gene expression of Spry2 and BDNF, a known inducer of Spry2, are down-regulated in the DLPFC of schizophrenia and bipolar subjects. Second, a significant positive correlation was observed between Spry2 and BDNF in schizophrenia, bipolar and normal subjects. Third, antipsychotic drug treatments showed differential effects on mRNA as well as protein levels of Spry2 and BDNF in rat frontal cortex.</p>
<a id="article1.body1.sec3.p2" name="article1.body1.sec3.p2"></a><p>The present study was conducted using the RNA samples from DLPFC area of schizophrenia, bipolar and normal subjects. Evidence from neuropsychological, neuroimaging, histopathological, and neurochemical studies implicate the role of DLPFC in the pathophysiology of schizophrenia <a href="#pone.0001784-Bunney1">[27]</a>. In addition, a number of studies have used the same set of samples obtained from Stanley Array Collection to examine various pathological markers in schizophrenia and bipolar disorder <a href="#pone.0001784-Xu1">[28]</a>-<a href="#pone.0001784-Mueller1">[30]</a>. Though there are a number of potential variables (age, PMI, brain pH, history of substance abuse, cause of death, alcohol use, or smoking), which can affect the quality of RNA as well as the gene expression status, the results from the present study did not show any significant correlation between BDNF or Spry2 mRNA levels and these confounding variables.</p>
<a id="article1.body1.sec3.p3" name="article1.body1.sec3.p3"></a><p>Spry2 is the prototypical member of a new family of RTK-signaling modulators, Sprouty proteins. The data from the present study suggest that Spry2 gene expression is significantly decreased in patients with either schizophrenia or bipolar disorder. It has been previously reported that BDNF stimulates Spry2 expression in neurons, and CREB and Sp1 are the two transcription factors that regulate Spry2 promoter activity in response to BDNF <a href="#pone.0001784-Gross1">[26]</a>. To determine whether BDNF is involved in the mechanism that contributed to decreased Spry2 expression in schizophrenia and bipolar subjects, the present study examined the correlation between the mRNA expression levels of Spry2 and BDNF. The changes in Spry2 mRNA expression were significantly correlated with BDNF mRNA expression in schizophrenia, bipolar and normal subjects suggesting the importance of BDNF in the regulation of Spry2 expression. However, further studies are needed to establish whether reduced expression of BDNF is sufficient to produce the altered expression of Spry2 in the DLPFC of subjects with schizophrenia or bipolar disorder since other growth factors, such EGF and FGF are also known to regulate Spry2 expression, at least in <em>in vitro</em> conditions <a href="#pone.0001784-Gross2">[31]</a>–<a href="#pone.0001784-Sasaki1">[33]</a>, and the transcription factors CREB and Sp1 are involved in other growth factor signaling pathways <a href="#pone.0001784-Xing1">[34]</a>–<a href="#pone.0001784-Merchant1">[35]</a>.</p>
<a id="article1.body1.sec3.p4" name="article1.body1.sec3.p4"></a><p>The data from antipsychotic-treated rats showed significant effect of haloperidol and olanzapine on Spry2 mRNA and protein levels in frontal cortex. The decrease in Spry2 expression after haloperidol treatment might be due to the adverse side effects of haloperidol after long-term treatment. It has been shown previously that neurotoxic stresses lead to reduction of Spry2 expression in mature neurons and the reduced Spry2 protein levels were significantly restored by BDNF treatment <a href="#pone.0001784-Gross1">[26]</a>. Long-term haloperidol-treatment has been shown to increase neurotoxicity markers, including pro-apoptotic proteins <a href="#pone.0001784-Jarskog1">[36]</a>–<a href="#pone.0001784-Pillai2">[37]</a>, and decrease BDNF protein levels in rat frontal cortex <a href="#pone.0001784-Pillai2">[37]</a>. In addition, compounds which can up-regulate BDNF signaling pathway have been shown to prevent haloperidol treatment-induced neuronal apoptosis <a href="#pone.0001784-Pillai2">[37]</a>. Spry2 protein levels were decreased in rat frontal cortex after olanzapine treatment with a parallel increase in BDNF protein levels. Since Spry2 is a known inhibitory molecule of cell proliferation and survival <a href="#pone.0001784-Mason1">[24]</a>–<a href="#pone.0001784-Kim1">[25]</a>, data on decreased Spry2 expression after olanzapine treatment is in agreement with the earlier reports that olanzapine treatment increases cell proliferation in rat frontal cortex <a href="#pone.0001784-Green1">[38]</a>–<a href="#pone.0001784-Kodama1">[39]</a>. Again, as in haloperidol-treated rats, the olanzapine-treated rats also showed an inverse relationship between BDNF and Spry2 expression. It is important to note that Spry2 expression can be induced upon growth factors such as EGF, FGF and BDNF <a href="#pone.0001784-Gross1">[26]</a>, <a href="#pone.0001784-Gross2">[31]</a>–<a href="#pone.0001784-Sasaki1">[33]</a>, whereas its expression can be downregulated by TGF-β1 <a href="#pone.0001784-Ding1">[40]</a>. Therefore, the changes observed in Spry2 expression would be the net effect of multiple growth factor signaling pathways. Interestingly, rodent studies have indicated that the beneficial effects of antipsychotic drugs are mediated through growth factor signaling pathways <a href="#pone.0001784-Angelucci1">[22]</a>–<a href="#pone.0001784-Pillai1">[23]</a>. This implies that the changes in Spry2 expression with antipsychotic-treatment may involve additional mechanisms other than BDNF signaling pathway.</p>
<a id="article1.body1.sec3.p5" name="article1.body1.sec3.p5"></a><p>The Spry2 gene regulates RTK signaling of many molecules such as EGF, EGF, VEGF and BDNF. These growth factors as well as neurotrophins play important roles in neuronal development and plasticity. Spry2 is of particular interest as a downstream target gene as well as a regulator for BDNF signaling. BDNF plays an important role in regulating dopaminergic, glutamatergic, and other neuronal signaling pathways, alterations of which are observed in schizophrenia <a href="#pone.0001784-Manji1">[41]</a>–<a href="#pone.0001784-Winder1">[42]</a>. Moreover, postmortem studies using brain samples from different cohorts showed changes in BDNF expression as well as the expression of its receptor, TrkB, in different brain areas of subjects with schizophrenia <a href="#pone.0001784-Weickert1">[10]</a>–<a href="#pone.0001784-Takahashi1">[15]</a>. There are a number of other RTK-binding molecules in addition to BDNF, which are implicated in schizophrenia. For example, neuregulin 1 <em>(</em>NRG1<em>)</em> is a potential susceptibility gene for schizophrenia <a href="#pone.0001784-Stefansson1">[43]</a>, and alterations in NRG1-ErbB signaling occur in the prefrontal cortex of schizophrenic patients <a href="#pone.0001784-Corfas1">[44]</a>–<a href="#pone.0001784-Hakak1">[45]</a>. NRG1-ErbB signaling regulates oligodendrocyte development and myelination <a href="#pone.0001784-Corfas1">[44]</a>, <a href="#pone.0001784-Michailov1">[46]</a> and abnormalities in oligodendroglia and myelin are reported in schizophrenia <a href="#pone.0001784-Davis1">[47]</a>. In addition, the role of EGF has been investigated recently in the pathophysiology of schizophrenia. Although one study reported abnormal expression of EGF and its receptor in the forebrain and serum of subjects with schizophrenia <a href="#pone.0001784-Futamura1">[48]</a>, another study could not find any significant change in the serum EGF levels in schizophrenia subjects compared to controls indicating the possibility that EGF may serve as a state marker, i.e., as an index of symptom-linked deficits <a href="#pone.0001784-Hashimoto2">[49]</a>. A recent study showed that knockdown of endogenous Disrupted-in-schizophrenia 1 (DISC1), a putative susceptibility gene for psychoses such as schizophrenia and bipolar disorder, by small interfering RNA in cortical neurons suppressed phosphorylation of ERK, but the exact mechanisms remain unknown <a href="#pone.0001784-Hashimoto3">[50]</a>. These studies indicate the possible involvement of Spry2 in the function of many genes currently implicated in schizophrenia.</p>
<a id="article1.body1.sec3.p6" name="article1.body1.sec3.p6"></a><p>Growth factors function through RTKs and activate Ras-ERK MAPK signaling to regulate numerous cellular events <a href="#pone.0001784-Schlessinger1">[51]</a>. ERK pathway has been implicated in regulation of neuronal function, cell survival and in learning and memory <a href="#pone.0001784-Sweatt1">[52]</a>. Spry2 specifically inhibits Ras-ERK MAPK signaling, leaving other MAPK and PI3K pathways unaffected <a href="#pone.0001784-Gross2">[31]</a>, <a href="#pone.0001784-Yusoff1">[53]</a>. Spry2 exerts differential effects on RTK-mediated signaling pathways at the level of Ras or Raf, depending upon the cell type and growth factor <a href="#pone.0001784-Mason1">[24]</a>–<a href="#pone.0001784-Kim1">[25]</a>, <a href="#pone.0001784-Xu1">[28]</a>. Spry2 inhibits FGF-induced ERK activation by interfering with FRS2/Shp2/Grb2 interactions <a href="#pone.0001784-Tefft1">[54]</a>, whereas it activates EGF-mediated ERK activation by preventing c-Cbl-mediated ubiquitination and endocytosis of activated EGFR <a href="#pone.0001784-Wong1">[55]</a>. Furthermore, a recent study showed that the reduced level of Spry2 induced by TGF-β1 is associated with inhibition of ERK activation in response to EGF stimulation <a href="#pone.0001784-Ding1">[40]</a>. The available literature on ERK signaling in postmortem brain samples from schizophrenia indicate a significant increase in ERK2 protein as well as mRNA levels in cerebellum samples from schizophrenia subjects <a href="#pone.0001784-Kyosseva1">[56]</a>. But, accumulating evidence from rodent studies indicate differential effects of antipsychotic drugs on ERK signaling in brain <a href="#pone.0001784-Browning1">[57]</a>–<a href="#pone.0001784-Pozzi1">[59]</a>. Therefore, additional studies are needed to correlate Spry2 expression and ERK signaling in schizophrenia, which will help to identify the downstream signaling pathways regulated by Spry2 in schizophrenia.</p>
<a id="article1.body1.sec3.p7" name="article1.body1.sec3.p7"></a><p>Taken together, our data from postmortem as well as animal studies indicate that the altered expression of Spry2 may be secondary to antipsychotic treatment rather than to factors that are significant in the disease process of either schizophrenia and/or bipolar disorder. The lack of correlation between the expression of Spry2 and antipsychotic medication at the time of death suggest that additional studies using more number of subjects with/without antipsychotic medication would be of great interest. Further exploration of Spry2-related signal transduction pathways will be helpful to design novel treatment strategies for schizophrenia and bipolar disorder.</p>
</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Materials and Methods"></a><h3>Materials and Methods</h3>
<h4>Human Postmortem Samples</h4>
<a id="article1.body1.sec4.sec1.p1" name="article1.body1.sec4.sec1.p1"></a><p>RNA samples from postmortem brain specimens, Brodmann's area 46 (in the DLPFC), from 35 individuals with schizophrenia, 31 individuals with bipolar disorder, and 34 psychiatrically normal controls were obtained from the Stanley Array Collection of the Stanley Brain Collection. A description of the Stanley Brain Collection and more detailed demographics and samples' quality were previously reported <a href="#pone.0001784-Torrey1">[60]</a>. RNA expression analysis was conducted with the samples coded to keep investigators blind to diagnostic status. At the time of sample decoding, diagnostic status and a range of clinical variables were provided for analysis (see <a href="#pone-0001784-t004">Table 4</a>).</p>
<div class="figure" id="pone-0001784-t004"><div class="img"><a name="pone-0001784-t004" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.t004&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001784" data-uri="info:doi/10.1371/journal.pone.0001784.t004"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.t004&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.t004/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.t004/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.t004/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.t004/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001784.t004.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.t004/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.t004/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001784.t004.TIF"></span>)
                </a></li></ul></div><p><strong>Table 4.  <span>Demographic data for post mortem brain samples.</span></strong></p><span>doi:10.1371/journal.pone.0001784.t004</span></div>

<h4>RNA quantification</h4>
<a id="article1.body1.sec4.sec2.p1" name="article1.body1.sec4.sec2.p1"></a><p>qRT-PCR was performed on a SmartCycler (Cepheid, Sunnyvale, CA) using a SuperScript III Platinum SYBR Green One-Step qRT-PCR kit (Invitrogen, Carlsbad, CA). Master mixes were prepared and used in the PCR amplifications. A typical reaction of a total volume of 25 µl consisted of 0.5 µl Superscript III RT/Platinum Taq mix, 12.5 µl 2X SYBR Green Reaction Mix (includes 0.4 mM of each dNTP and 6 mM MgSO4), 12.5 pMol of each of forward or reverse primers and 5 µl DEPC-treated water. Approximately 0.5–1.0 µg RNA was used as template. PCR amplification was done with an initial incubation at 55°C for 120 sec, then at 95°C for 120 sec followed by 35 cycles of 95°C for 15 sec, 50°C for 30 sec, 72°C for 30 sec and final melting curve from 55°C to 95°C with 0.2C/sec. The standard curve used for determining the relative quantity in each sample was constructed by the amplification of serial dilutions of cDNA. Primer specificity was confirmed by melting curve analysis and electrophoresis of PCR products on a 2% agarose gel to confirm the presence of a single band of the predicted size. All measurements were performed in triplicates. The data were normalized to three control genes (glyceraldehyde 3-phosphate dehydrogenase (GAPDH), <em>ß</em>-2-microglobulin (β2-MG) and <em>ß</em>-actin) and a geometric mean of these genes. Primers utilized are listed in <a href="#pone-0001784-t005">Table 5</a>.</p>
<div class="figure" id="pone-0001784-t005"><div class="img"><a name="pone-0001784-t005" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.t005&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001784" data-uri="info:doi/10.1371/journal.pone.0001784.t005"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001784.t005&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.t005/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.t005/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.t005/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.t005/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001784.t005.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001784.t005/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001784.t005/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001784.t005.TIF"></span>)
                </a></li></ul></div><p><strong>Table 5.  <span>List of primer sequences used for postmortem studies.</span></strong></p><span>doi:10.1371/journal.pone.0001784.t005</span></div>

<h4>Animal experiments</h4>
<h5>Animals.</h5><a id="article1.body1.sec4.sec3.sec1.p1" name="article1.body1.sec4.sec3.sec1.p1"></a><p>Adult male albino rats (weighing 225–250 g; Harlan Sprague–Dawley, Inc., Indianapolis, IN, USA) were housed singly under a 12-h light/12-h dark cycle and at a constant temperature (25°C) and humidity, and allowed free access to food and water. Animal use procedures were performed after being reviewed and approved by Medical College of Georgia Committee on Animal Use for Research (CAURE) and Veterans Affair Medical Center Subcommittee on Animal use. The procedures were consistent with Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) guidelines as per Public Health Service Policy on Humane Care and Use of Laboratory Animals.</p>

<h5>Drug treatment.</h5><a id="article1.body1.sec4.sec3.sec2.p1" name="article1.body1.sec4.sec3.sec2.p1"></a><p>Haloperidol (Sigma Chemical Company, St Louis, MO, USA) and olanzapine (A &amp; A Pharmachem; Toronto, ON, Canada) were dissolved in a 0.1-M acetic acid and subsequently diluted (1:100) with tap water to administer the final daily dose of drug. All drugs were prepared daily and administered in solutions, which replaced drinking water. The amount of drug intake was measured every day and adjustments were made depending upon the fluid consumed and weight of the animals. This method was preferred over multiple intramuscular injections to maintain more constant drug levels and to reduce stress and neuromuscular damage. Rats (n  = 10–12 per group) received haloperidol (2 mg/kg/day) or olanzapine (10 mg/kg/day) for 45 days. The haloperidol dose was chosen based on previous studies <a href="#pone.0001784-Pillai1">[23]</a>, in which it was found to result in plasma levels comparable to therapeutic plasma levels in humans. This dose is also comparable to the dose optimum for pharmacological effects <a href="#pone.0001784-Didriksen1">[61]</a>–<a href="#pone.0001784-Skarsfeldt1">[63]</a>. The choice of olanzapine, a representative atypical antipsychotic, and its dose and duration of treatment was based on their different pharmacological and clinical profiles, and neurochemical effects reported in a large number of earlier studies <a href="#pone.0001784-Pillai1">[23]</a>, <a href="#pone.0001784-Kinon1">[64]</a>–<a href="#pone.0001784-Terry2">[66]</a>. Tap water containing 0.1 M acetic acid was used for the control group to assure that an unanticipated effect of the vehicle was not present.</p>



<h4>RNA quantification in rat frontal cortex samples</h4>
<a id="article1.body1.sec4.sec4.p1" name="article1.body1.sec4.sec4.p1"></a><p>Frontal cortex samples from vehicle and antipsychotic-treated rats were collected and RNA was extracted using a commercially available kit (SV RNA Isolation, Promega, Madison, WI), according to manufacturer's instructions. mRNA was measured using a SuperScript III Platinum SYBR Green One-Step qRT-PCR kit as described earlier for human tissue with the following primers: Sprouty2: (629–811 base pairs, Gen Bank accession No: NM_011897, forward primer <span class="gene">5′-GGGTCTCGGAGCAGTACAAGG-3′</span>; reverse primer <span class="gene">5′-GTAGGCATGCAGACCCAAAT-3′</span>), BDNF (1115-1363 base pairs, Gen Bank accession No: NM_007540, forward primer <span class="gene">5′-GCGGCAGATAAAAAGACTGC-3′</span>; reverse primer <span class="gene">5′- CTTATGAATCGCCAGCCAAT -3′</span>) and housekeeping gene, ribosomal protein S3 (RPS3) (284-466 base pairs, Gen Bank accession No: NM_012052, forward primer <span class="gene">5′-AATGAACCGAAGCACACCATA-3′</span>; reverse primer <span class="gene">5′-ATCAGAGAGTTGACCGCAGTT-3′</span>).</p>


<h4>Protein quantification in rat frontal cortex samples</h4>
<a id="article1.body1.sec4.sec5.p1" name="article1.body1.sec4.sec5.p1"></a><p>Frontal cortex samples were collected and homogenized in ice-cold buffer (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% SDS, 1% Nonidet P-40, 1% sodium deoxycholate) supplemented with protease inhibitor cocktail (Sigma) containing 104 mM AEBSF, 0.08 mM aprotinin, 2 mM leupeptin, 4 mM bestatin, 1.5 mM pepstatin A, and 1.4 mM E-64. After 15-min incubation on ice, the extracts were clarified by centrifugation at 14,000 rpm for 15 min at 4°C and stored at –70°C. Protein concentrations were determined by the bicinchoninic acid method (BCA Protein Assay Kit, Sigma). Equal amounts of protein were resolved in SDS-polyacrylamide gels and transferred electrophoretically onto a nitrocellulose membrane (Bio-Rad, Hercules, California, United States). Membranes were blocked for 1 h in TBST (10mM Tris-HCl, pH 8.0, 138 mM NaCl, 2.7 mM KCl, and 0.05% Tween-20) and 5% non-fat milk and incubated overnight with a rabbit antibody to sprouty2 (Santa Cruz Biotechnology, Santa Cruz, California, United States) and visualized using ECL (Pierce, Rockford, Illinois, United States) with a secondary antibody coupled to horseradish peroxidase. For actin normalization, blots were incubated in strip buffer (62.5 mM Tris-HCl [pH 7.4], 2% SDS, and 90 mM β-mercaptoethanol) at 65°C for 20 min with agitation, followed by probing with a rabbit antibody to β-actin (the antigen corresponds to amino acids 20–33, conserved in all actin isoforms) as described above. To ensure that quantification used an exposure that was within the linear range of the film used to image the blot, a series of images with increasing exposure time to the blot were developed. The intensity of the bands on each image was quantified using Quantity one software (Bio-Rad) after normalizing to the expression of β-actin.</p>


<h4>Brain-derived Neurotrophic Factor (BDNF) Immunoassay</h4>
<a id="article1.body1.sec4.sec6.p1" name="article1.body1.sec4.sec6.p1"></a><p>BDNF protein was measured with a conventional sandwich ELISA using the BDNF Emax immunoassay system (Promega, Madison, WI, USA) according to the protocol of the manufacturer.</p>


<h4>Statistical analysis</h4>
<a id="article1.body1.sec4.sec7.p1" name="article1.body1.sec4.sec7.p1"></a><p>The mean quantity value for Spry2 or BDNF mRNA for each individual was normalized to the geometric mean of the three housekeeping genes to obtain the relative amount of each transcript in each individual. Continuous variables (age at death, postmortem interval, brain pH, brain weight and refrigeration interval) were tested by regression; dichotomous variables (gender, brain hemisphere analyzed, smoking status at time of death, age of onset, duration of illness, and history of exposure to antipsychotic medication) and ordinal variables (lifetime alcohol use and lifetime substance abuse) were tested by ANOVA. The strength of the association with Spry2 or BDNF expression was measured with Pearson's product moment correlation for continuous variables and Kendall's rank correlation for binary and ordinal variables. Effect of exposure to antipsychotics on Spry2 and BDNF mRNA as well as protein levels in rats were analyzed by one-way ANOVA followed by post-hoc Dunnett test with comparison to the vehicle-treatment group. Differences in means between groups were considered significant if p&lt;0.05. SPSS version 14.0 software was used for statistical analyses.</p>

</div>





<div><a id="ack" name="ack" toc="ack" title="Acknowledgments"></a><h3>Acknowledgments</h3>
<a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1"></a><p>RNA samples were donated by The Stanley Medical Research Institute's brain collection courtesy of Drs. Michael B. Knable, E. Fuller Torrey, Maree J. Webster, and Robert H. Yolken. Dr. Pillai is thankful to Dr. Dhandapani for his help during PCR analysis. Dr. Pillai acknowledges Drs. Mahadik and Buckley for their support during the study.</p>
</div><div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: AP. Performed the experiments: AP. Analyzed the data: AP. Contributed reagents/materials/analysis tools: AP. Wrote the paper: AP.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0001784-BenShachar1" id="pone.0001784-BenShachar1"></a>Ben-Shachar D, Laifenfeld D (2004) Mitochondria, synaptic plasticity, and schizophrenia. Int Rev Neurobiol  59: 273–296.  <ul class="find" data-citedArticleID="1073144" data-doi="10.1016/s0074-7742(04)59011-6"><li><a href="http://dx.doi.org/10.1016/s0074-7742(04)59011-6" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mitochondria%2C+synaptic+plasticity%2C+and+schizophrenia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mitochondria%2C+synaptic+plasticity%2C+and+schizophrenia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0001784-Eastwood1" id="pone.0001784-Eastwood1"></a>Eastwood SL (2004) The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame? Int Rev Neurobiol  59: 47–72.  <ul class="find" data-citedArticleID="1073172" data-doi="10.1016/s0074-7742(04)59003-7"><li><a href="http://dx.doi.org/10.1016/s0074-7742(04)59003-7" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+synaptic+pathology+of+schizophrenia%3A+is+aberrant+neurodevelopment+and+plasticity+to+blame%3F" target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+synaptic+pathology+of+schizophrenia%3A+is+aberrant+neurodevelopment+and+plasticity+to+blame%3F%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0001784-Arnold1" id="pone.0001784-Arnold1"></a>Arnold SE, Talbot K, Hahn CG (2005) Neurodevelopment, neuroplasticity, and new genes for schizophrenia. Prog Brain Res  147: 319–345.  <ul class="find" data-citedArticleID="1073142" data-doi="10.1016/s0079-6123(04)47023-x"><li><a href="http://dx.doi.org/10.1016/s0079-6123(04)47023-x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Neurodevelopment%2C+neuroplasticity%2C+and+new+genes+for+schizophrenia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Neurodevelopment%2C+neuroplasticity%2C+and+new+genes+for+schizophrenia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0001784-Rylett1" id="pone.0001784-Rylett1"></a>Rylett RJ, Williams LR (1994) Role of neurotrophins in cholinergic-neuron function in the adult and aged CNS. Trends Neurosci  17: 486–490.  <ul class="find" data-citedArticleID="1073226" data-doi="10.1016/0166-2236(94)90138-4"><li><a href="http://dx.doi.org/10.1016/0166-2236(94)90138-4" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Role+of+neurotrophins+in+cholinergic-neuron+function+in+the+adult+and+aged+CNS." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Role+of+neurotrophins+in+cholinergic-neuron+function+in+the+adult+and+aged+CNS.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0001784-Cellerino1" id="pone.0001784-Cellerino1"></a>Cellerino A, Carroll P, Thoenen H, Barde YA (1997) Reduced size of retinal ganglion cell axons and hypomyelination in mice lacking brain-derived neurotrophic factor. Mol Cell Neurosci  9: 397–408.  <ul class="find" data-citedArticleID="1073158" data-doi="10.1006/mcne.1997.0641"><li><a href="http://dx.doi.org/10.1006/mcne.1997.0641" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Reduced+size+of+retinal+ganglion+cell+axons+and+hypomyelination+in+mice+lacking+brain-derived+neurotrophic+factor." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Reduced+size+of+retinal+ganglion+cell+axons+and+hypomyelination+in+mice+lacking+brain-derived+neurotrophic+factor.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0001784-Pizzorusso1" id="pone.0001784-Pizzorusso1"></a>Pizzorusso T, Maffei L (1996) Plasticity in the developing visual system. Curr Opin Neurol  9: 122–125.  <ul class="find" data-citedArticleID="1073222" data-doi="10.1097/00019052-199604000-00012"><li><a href="http://dx.doi.org/10.1097/00019052-199604000-00012" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Plasticity+in+the+developing+visual+system." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Plasticity+in+the+developing+visual+system.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0001784-Bramham1" id="pone.0001784-Bramham1"></a>Bramham CR, Messaoudi E (2005) BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol  76: 99–125.  <ul class="find" data-citedArticleID="1073146" data-doi="10.1016/j.pneurobio.2005.06.003"><li><a href="http://dx.doi.org/10.1016/j.pneurobio.2005.06.003" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=BDNF+function+in+adult+synaptic+plasticity%3A+the+synaptic+consolidation+hypothesis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22BDNF+function+in+adult+synaptic+plasticity%3A+the+synaptic+consolidation+hypothesis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0001784-Shoval1" id="pone.0001784-Shoval1"></a>Shoval G, Weizman A (2005) The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia. Eur Neuropsychopharmacol  15: 319–329.  <ul class="find" data-citedArticleID="1073234" data-doi="10.1016/j.euroneuro.2004.12.005"><li><a href="http://dx.doi.org/10.1016/j.euroneuro.2004.12.005" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+possible+role+of+neurotrophins+in+the+pathogenesis+and+therapy+of+schizophrenia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+possible+role+of+neurotrophins+in+the+pathogenesis+and+therapy+of+schizophrenia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0001784-Buckley1" id="pone.0001784-Buckley1"></a>Buckley PF, Mahadik S, Pillai A, Terry A Jr (2007) Neurotrophins and schizophrenia. Schizophr Res  94: 1–11.  <ul class="find" data-citedArticleID="1073150" data-doi="10.1016/j.schres.2007.01.025"><li><a href="http://dx.doi.org/10.1016/j.schres.2007.01.025" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Neurotrophins+and+schizophrenia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Neurotrophins+and+schizophrenia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0001784-Weickert1" id="pone.0001784-Weickert1"></a>Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, et al.  (2003) Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry  8: 592–610.  <ul class="find" data-citedArticleID="1073256" data-doi="10.1038/sj.mp.4001308"><li><a href="http://dx.doi.org/10.1038/sj.mp.4001308" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Reduced+brain-derived+neurotrophic+factor+in+prefrontal+cortex+of+patients+with+schizophrenia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Reduced+brain-derived+neurotrophic+factor+in+prefrontal+cortex+of+patients+with+schizophrenia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0001784-Weickert2" id="pone.0001784-Weickert2"></a>Weickert CS, Ligons DL, Romanczyk T, Ungaro G, Hyde TM, et al.  (2005) Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia. Mol Psychiatry  10: 637–650.  <ul class="find" data-citedArticleID="1073258" data-doi="10.1038/sj.mp.4001678"><li><a href="http://dx.doi.org/10.1038/sj.mp.4001678" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Reductions+in+neurotrophin+receptor+mRNAs+in+the+prefrontal+cortex+of+patients+with+schizophrenia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Reductions+in+neurotrophin+receptor+mRNAs+in+the+prefrontal+cortex+of+patients+with+schizophrenia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0001784-Hashimoto1" id="pone.0001784-Hashimoto1"></a>Hashimoto T, Bergen SE, Nguyen QL, Xu B, Monteggia LM, et al.  (2005) Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J Neurosci  25: 372–383.  <ul class="find" data-citedArticleID="1073186" data-doi="10.1523/jneurosci.4035-04.2005"><li><a href="http://dx.doi.org/10.1523/jneurosci.4035-04.2005" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Relationship+of+brain-derived+neurotrophic+factor+and+its+receptor+TrkB+to+altered+inhibitory+prefrontal+circuitry+in+schizophrenia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Relationship+of+brain-derived+neurotrophic+factor+and+its+receptor+TrkB+to+altered+inhibitory+prefrontal+circuitry+in+schizophrenia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0001784-Durany1" id="pone.0001784-Durany1"></a>Durany T, Michel R, Zochling KW, Boissl FF, Cruz-Sanchez F, et al.  (2001) Brain derived neurotrophic factor and neurotrophin-3 in schizophrenic psychoses. Schizophrenia Res  52: 79–86.  <ul class="find" data-citedArticleID="1073170" data-doi="10.1016/s0920-9964(00)00084-0"><li><a href="http://dx.doi.org/10.1016/s0920-9964(00)00084-0" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Brain+derived+neurotrophic+factor+and+neurotrophin-3+in+schizophrenic+psychoses." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Brain+derived+neurotrophic+factor+and+neurotrophin-3+in+schizophrenic+psychoses.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0001784-Iritani1" id="pone.0001784-Iritani1"></a>Iritani S, Niizato K, Hawa H, et al.  (2003) Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains. Progress in Neuro-Psychopharmacology and Biological Psychiatry  27: 801–807.  <ul class="find" data-citedArticleID="1073194" data-doi="10.1016/s0278-5846(03)00112-x"><li><a href="http://dx.doi.org/10.1016/s0278-5846(03)00112-x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Immunohistochemical+study+of+brain-derived+neurotrophic+factor+and+its+receptor%2C+TrkB%2C+in+the+hippocampal+formation+of+schizophrenic+brains." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Immunohistochemical+study+of+brain-derived+neurotrophic+factor+and+its+receptor%2C+TrkB%2C+in+the+hippocampal+formation+of+schizophrenic+brains.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0001784-Takahashi1" id="pone.0001784-Takahashi1"></a>Takahashi M, Shirakawa O, Toyooka K, Kitamura N, Hashimoto T, et al.  (2000) Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol Psychiatry  5: 293–300.  <ul class="find" data-citedArticleID="1073242" data-doi="10.1038/sj.mp.4000718"><li><a href="http://dx.doi.org/10.1038/sj.mp.4000718" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Abnormal+expression+of+brain-derived+neurotrophic+factor+and+its+receptor+in+the+corticolimbic+system+of+schizophrenic+patients." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Abnormal+expression+of+brain-derived+neurotrophic+factor+and+its+receptor+in+the+corticolimbic+system+of+schizophrenic+patients.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0001784-Toyooka1" id="pone.0001784-Toyooka1"></a>Toyooka K, Asama K, Watanabe Y, Muratake T, Takahashi M, et al.  (2002) Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res  110: 249–257.  <ul class="find" data-citedArticleID="1073254" data-doi="10.1016/s0165-1781(02)00127-0"><li><a href="http://dx.doi.org/10.1016/s0165-1781(02)00127-0" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Decreased+levels+of+brain-derived+neurotrophic+factor+in+serum+of+chronic+schizophrenic+patients." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Decreased+levels+of+brain-derived+neurotrophic+factor+in+serum+of+chronic+schizophrenic+patients.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0001784-Tan1" id="pone.0001784-Tan1"></a>Tan YL, Zhou DF, Zhang XY (2005) Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements. Schizophr Res  74: 263–270.  <ul class="find" data-citedArticleID="1073244" data-doi="10.1016/j.schres.2004.08.004"><li><a href="http://dx.doi.org/10.1016/j.schres.2004.08.004" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Decreased+plasma+brain-derived+neurotrophic+factor+levels+in+schizophrenic+patients+with+tardive+dyskinesia%3A+association+with+dyskinetic+movements." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Decreased+plasma+brain-derived+neurotrophic+factor+levels+in+schizophrenic+patients+with+tardive+dyskinesia%3A+association+with+dyskinetic+movements.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">18.
              </span><a name="pone.0001784-Grillo1" id="pone.0001784-Grillo1"></a>Grillo RW, Ottoni GL, Leke R, Souza DO, Portela LV, et al.  (2007) Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics. J Psychiatr Res  4: 31–35.  <ul class="find" data-citedArticleID="1073178" data-doi="10.1016/j.jpsychires.2006.01.005"><li><a href="http://dx.doi.org/10.1016/j.jpsychires.2006.01.005" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Reduced+serum+BDNF+levels+in+schizophrenic+patients+on+clozapine+or+typical+antipsychotics." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Reduced+serum+BDNF+levels+in+schizophrenic+patients+on+clozapine+or+typical+antipsychotics.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0001784-Shimizu1" id="pone.0001784-Shimizu1"></a>Shimizu E, Hashimoto K, Watanabe H, Komatsu N, Okamura N, et al.  (2003) Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls. Neurosci Lett  351: 111–114.  <ul class="find" data-citedArticleID="1073232" data-doi="10.1016/j.neulet.2003.08.004"><li><a href="http://dx.doi.org/10.1016/j.neulet.2003.08.004" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Serum+brain-derived+neurotrophic+factor+%28BDNF%29+levels+in+schizophrenia+are+indistinguishable+from+controls." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Serum+brain-derived+neurotrophic+factor+%28BDNF%29+levels+in+schizophrenia+are+indistinguishable+from+controls.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0001784-JockersScherbl1" id="pone.0001784-JockersScherbl1"></a>Jockers-Scherübl MC, Danker-Hopfe H, Mahlberg R, Selig F, Rentzsch J, et al.  (2004) Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse. Neurosci Lett  371: 79–83.  <ul class="find" data-citedArticleID="1073198" data-doi="10.1016/j.neulet.2004.08.045"><li><a href="http://dx.doi.org/10.1016/j.neulet.2004.08.045" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Brain-derived+neurotrophic+factor+serum+concentrations+are+increased+in+drug-naive+schizophrenic+patients+with+chronic+cannabis+abuse+and+multiple+substance+abuse." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Brain-derived+neurotrophic+factor+serum+concentrations+are+increased+in+drug-naive+schizophrenic+patients+with+chronic+cannabis+abuse+and+multiple+substance+abuse.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">21.
              </span><a name="pone.0001784-Buckley2" id="pone.0001784-Buckley2"></a>Buckley PF, Pillai A, Evans D, Stirewalt E, Mahadik S (2007) Brain derived neurotrophic factor in first-episode psychosis. Schizophr Res  91: 1–5.  <ul class="find" data-citedArticleID="1073152" data-doi="10.1016/j.schres.2006.12.026"><li><a href="http://dx.doi.org/10.1016/j.schres.2006.12.026" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Brain+derived+neurotrophic+factor+in+first-episode+psychosis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Brain+derived+neurotrophic+factor+in+first-episode+psychosis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">22.
              </span><a name="pone.0001784-Angelucci1" id="pone.0001784-Angelucci1"></a>Angelucci F, Aloe L, Gruber SH, Fiore M, Mathe AA (2000) Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyl transferase in rat brain regions. Int J Neuropsychopharmacol  3: 13–25.  <ul class="find" data-citedArticleID="1073140" data-doi="10.1017/s1461145700001759"><li><a href="http://dx.doi.org/10.1017/s1461145700001759" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Chronic+antipsychotic+treatment+selectively+alters+nerve+growth+factor+and+neuropeptide+Y+immunoreactivity+and+the+distribution+of+choline+acetyl+transferase+in+rat+brain+regions." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Chronic+antipsychotic+treatment+selectively+alters+nerve+growth+factor+and+neuropeptide+Y+immunoreactivity+and+the+distribution+of+choline+acetyl+transferase+in+rat+brain+regions.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">23.
              </span><a name="pone.0001784-Pillai1" id="pone.0001784-Pillai1"></a>Pillai A, Terry AV Jr, Mahadik SP (2006) Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus. Schizophr Res  82: 95–106.  <ul class="find" data-citedArticleID="1073218" data-doi="10.1016/j.schres.2005.11.021"><li><a href="http://dx.doi.org/10.1016/j.schres.2005.11.021" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Differential+effects+of+long-term+treatment+with+typical+and+atypical+antipsychotics+on+NGF+and+BDNF+levels+in+rat+striatum+and+hippocampus." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Differential+effects+of+long-term+treatment+with+typical+and+atypical+antipsychotics+on+NGF+and+BDNF+levels+in+rat+striatum+and+hippocampus.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">24.
              </span><a name="pone.0001784-Mason1" id="pone.0001784-Mason1"></a>Mason JM, Morrison DJ, Basson MA, Licht JD (2006) Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. Trends Cell Biol  16: 45–54.  <ul class="find" data-citedArticleID="1073210" data-doi="10.1016/j.tcb.2005.11.004"><li><a href="http://dx.doi.org/10.1016/j.tcb.2005.11.004" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Sprouty+proteins%3A+multifaceted+negative-feedback+regulators+of+receptor+tyrosine+kinase+signaling." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Sprouty+proteins%3A+multifaceted+negative-feedback+regulators+of+receptor+tyrosine+kinase+signaling.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">25.
              </span><a name="pone.0001784-Kim1" id="pone.0001784-Kim1"></a>Kim HJ, Bar-Sagi D (2004) Modulation of signalling by Sprouty: a developing story. Nat Rev Mol Cell Biol  5: 441–450.  <ul class="find" data-citedArticleID="1073200" data-doi="10.1038/nrm1400"><li><a href="http://dx.doi.org/10.1038/nrm1400" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Modulation+of+signalling+by+Sprouty%3A+a+developing+story." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Modulation+of+signalling+by+Sprouty%3A+a+developing+story.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">26.
              </span><a name="pone.0001784-Gross1" id="pone.0001784-Gross1"></a>Gross I, Armant O, Benosman S, de Aguilar JL, Freund JN, et al.  (2007) Sprouty2 inhibits BDNF-induced signaling and modulates neuronal differentiation and survival. Cell Death Differ  14: 1802–1812.  <ul class="find" data-citedArticleID="1073180" data-doi="10.1038/sj.cdd.4402188"><li><a href="http://dx.doi.org/10.1038/sj.cdd.4402188" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Sprouty2+inhibits+BDNF-induced+signaling+and+modulates+neuronal+differentiation+and+survival." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Sprouty2+inhibits+BDNF-induced+signaling+and+modulates+neuronal+differentiation+and+survival.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">27.
              </span><a name="pone.0001784-Bunney1" id="pone.0001784-Bunney1"></a>Bunney WE, Bunney BG (2000) Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia. Brain Res Brain Res Rev  31: 138–146.  <ul class="find" data-citedArticleID="1073154" data-doi="10.1016/s0165-0173(99)00031-4"><li><a href="http://dx.doi.org/10.1016/s0165-0173(99)00031-4" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Evidence+for+a+compromised+dorsolateral+prefrontal+cortical+parallel+circuit+in+schizophrenia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Evidence+for+a+compromised+dorsolateral+prefrontal+cortical+parallel+circuit+in+schizophrenia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">28.
              </span><a name="pone.0001784-Xu1" id="pone.0001784-Xu1"></a>Xu B, Wratten N, Charych EI, Buyske S, Firestein BL, et al.  (2005) Increased expression in dorsolateral prefrontal cortex of CAPON in schizophrenia and bipolar disorder. PLoS Med  2: e263.  <ul class="find" data-citedArticleID="1073266" data-doi="10.1371/journal.pmed.0020263"><li><a href="http://dx.doi.org/10.1371/journal.pmed.0020263" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Increased+expression+in+dorsolateral+prefrontal+cortex+of+CAPON+in+schizophrenia+and+bipolar+disorder." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Increased+expression+in+dorsolateral+prefrontal+cortex+of+CAPON+in+schizophrenia+and+bipolar+disorder.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">29.
              </span><a name="pone.0001784-DeLuca1" id="pone.0001784-DeLuca1"></a>De Luca V, Likhodi O, Van Tol HH, Kennedy JL, Wong AH (2005) Tryptophan hydroxylase 2 gene expression and promoter polymorphisms in bipolar disorder and schizophrenia. Psychopharmacology (Berl)  183: 378–382.  <ul class="find" data-citedArticleID="1073164" data-doi="10.1007/s00213-005-0191-4"><li><a href="http://dx.doi.org/10.1007/s00213-005-0191-4" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Tryptophan+hydroxylase+2+gene+expression+and+promoter+polymorphisms+in+bipolar+disorder+and+schizophrenia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Tryptophan+hydroxylase+2+gene+expression+and+promoter+polymorphisms+in+bipolar+disorder+and+schizophrenia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">30.
              </span><a name="pone.0001784-Mueller1" id="pone.0001784-Mueller1"></a>Mueller HT, Meador-Woodruff JH (2004) NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder. Schizophr Res  71: 361–370.  <ul class="find" data-citedArticleID="1073216" data-doi="10.1016/j.schres.2004.02.016"><li><a href="http://dx.doi.org/10.1016/j.schres.2004.02.016" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=NR3A+NMDA+receptor+subunit+mRNA+expression+in+schizophrenia%2C+depression+and+bipolar+disorder." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22NR3A+NMDA+receptor+subunit+mRNA+expression+in+schizophrenia%2C+depression+and+bipolar+disorder.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">31.
              </span><a name="pone.0001784-Gross2" id="pone.0001784-Gross2"></a>Gross I, Bassit B, Benezra M, Licht JD (2001) Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation. J Biol Chem  276: 46460–46468.  <ul class="find" data-citedArticleID="1073182" data-doi="10.1074/jbc.m108234200"><li><a href="http://dx.doi.org/10.1074/jbc.m108234200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mammalian+sprouty+proteins+inhibit+cell+growth+and+differentiation+by+preventing+ras+activation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mammalian+sprouty+proteins+inhibit+cell+growth+and+differentiation+by+preventing+ras+activation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">32.
              </span><a name="pone.0001784-Impagnatiello1" id="pone.0001784-Impagnatiello1"></a>Impagnatiello MA, Weitzer S, Gannon G, Compagni A, Cotten M, et al.  (2001) Mammalian sprouty-1 and -2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells. J Cell Biol  152: 1087–1098.  <ul class="find" data-citedArticleID="1073192" data-doi="10.1083/jcb.152.5.1087"><li><a href="http://dx.doi.org/10.1083/jcb.152.5.1087" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mammalian+sprouty-1+and+-2+are+membrane-anchored+phosphoprotein+inhibitors+of+growth+factor+signaling+in+endothelial+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mammalian+sprouty-1+and+-2+are+membrane-anchored+phosphoprotein+inhibitors+of+growth+factor+signaling+in+endothelial+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">33.
              </span><a name="pone.0001784-Sasaki1" id="pone.0001784-Sasaki1"></a>Sasaki A, Taketomi T, Wakioka T, Kato R, Yoshimura A (2001) Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activation. J Biol Chem  276: 36804–36808.  <ul class="find" data-citedArticleID="1073228" data-doi="10.1074/jbc.c100386200"><li><a href="http://dx.doi.org/10.1074/jbc.c100386200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Identification+of+a+dominant+negative+mutant+of+Sprouty+that+potentiates+fibroblast+growth+factor-+but+not+epidermal+growth+factor-induced+ERK+activation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Identification+of+a+dominant+negative+mutant+of+Sprouty+that+potentiates+fibroblast+growth+factor-+but+not+epidermal+growth+factor-induced+ERK+activation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">34.
              </span><a name="pone.0001784-Xing1" id="pone.0001784-Xing1"></a>Xing J, Kornhauser JM, Xia Z, Thiele EA, Greenberg ME (1998) Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. Mol Cell Biol  18: 1946–1955.  <ul class="find" data-citedArticleID="1073264"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Nerve+growth+factor+activates+extracellular+signal-regulated+kinase+and+p38+mitogen-activated+protein+kinase+pathways+to+stimulate+CREB+serine+133+phosphorylation.&amp;auth=&amp;atitle=Nerve+growth+factor+activates+extracellular+signal-regulated+kinase+and+p38+mitogen-activated+protein+kinase+pathways+to+stimulate+CREB+serine+133+phosphorylation." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Nerve+growth+factor+activates+extracellular+signal-regulated+kinase+and+p38+mitogen-activated+protein+kinase+pathways+to+stimulate+CREB+serine+133+phosphorylation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Nerve+growth+factor+activates+extracellular+signal-regulated+kinase+and+p38+mitogen-activated+protein+kinase+pathways+to+stimulate+CREB+serine+133+phosphorylation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">35.
              </span><a name="pone.0001784-Merchant1" id="pone.0001784-Merchant1"></a>Merchant JL, Du M, Todisco A (1999) Sp1 phosphorylation by Erk 2 stimulates DNA binding. Biochem Biophys Res Commun  254: 454–461.  <ul class="find" data-citedArticleID="1073212" data-doi="10.1006/bbrc.1998.9964"><li><a href="http://dx.doi.org/10.1006/bbrc.1998.9964" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Sp1+phosphorylation+by+Erk+2+stimulates+DNA+binding." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Sp1+phosphorylation+by+Erk+2+stimulates+DNA+binding.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">36.
              </span><a name="pone.0001784-Jarskog1" id="pone.0001784-Jarskog1"></a>Jarskog LF, Gilmore JH, Glantz LA, Gable KL, German TT, et al.  (2007) Caspase-3 activation in rat frontal cortex following treatment with typical and atypical antipsychotics. Neuropsychopharmacology  32: 95–102.  <ul class="find" data-citedArticleID="1073196" data-doi="10.1038/sj.npp.1301074"><li><a href="http://dx.doi.org/10.1038/sj.npp.1301074" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Caspase-3+activation+in+rat+frontal+cortex+following+treatment+with+typical+and+atypical+antipsychotics." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Caspase-3+activation+in+rat+frontal+cortex+following+treatment+with+typical+and+atypical+antipsychotics.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">37.
              </span><a name="pone.0001784-Pillai2" id="pone.0001784-Pillai2"></a>Pillai A, Dhandapani KM, Pillai BA, Terry AV Jr, Mahadik SP (2007) Erythropoietin Prevents Haloperidol Treatment-Induced Neuronal Apoptosis through Regulation of BDNF. Neuropsychopharmacology Sep 5.   <ul class="find" data-citedArticleID="1073220" data-doi="10.1038/sj.npp.1301566"><li><a href="http://dx.doi.org/10.1038/sj.npp.1301566" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Erythropoietin+Prevents+Haloperidol+Treatment-Induced+Neuronal+Apoptosis+through+Regulation+of+BDNF." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Erythropoietin+Prevents+Haloperidol+Treatment-Induced+Neuronal+Apoptosis+through+Regulation+of+BDNF.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">38.
              </span><a name="pone.0001784-Green1" id="pone.0001784-Green1"></a>Green W, Patil P, Marsden CA, Bennett GW, Wigmore PM (2006) Treatment with olanzapine increases cell proliferation in the subventricular zone and prefrontal cortex. Brain Res  1070: 242–245.  <ul class="find" data-citedArticleID="1073176" data-doi="10.1016/j.brainres.2005.11.047"><li><a href="http://dx.doi.org/10.1016/j.brainres.2005.11.047" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Treatment+with+olanzapine+increases+cell+proliferation+in+the+subventricular+zone+and+prefrontal+cortex." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Treatment+with+olanzapine+increases+cell+proliferation+in+the+subventricular+zone+and+prefrontal+cortex.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">39.
              </span><a name="pone.0001784-Kodama1" id="pone.0001784-Kodama1"></a>Kodama M, Fujioka T, Duman RS (2004) Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol Psychiatry  56: 570–580.  <ul class="find" data-citedArticleID="1073204" data-doi="10.1016/j.biopsych.2004.07.008"><li><a href="http://dx.doi.org/10.1016/j.biopsych.2004.07.008" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Chronic+olanzapine+or+fluoxetine+administration+increases+cell+proliferation+in+hippocampus+and+prefrontal+cortex+of+adult+rat." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Chronic+olanzapine+or+fluoxetine+administration+increases+cell+proliferation+in+hippocampus+and+prefrontal+cortex+of+adult+rat.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">40.
              </span><a name="pone.0001784-Ding1" id="pone.0001784-Ding1"></a>Ding W, Shi W, Bellusci S, Groffen J, Heisterkamp N, et al.  (2007) Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells. J Cell Physiol  212: 796–806.  <ul class="find" data-citedArticleID="1073168" data-doi="10.1002/jcp.21078"><li><a href="http://dx.doi.org/10.1002/jcp.21078" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Sprouty2+downregulation+plays+a+pivotal+role+in+mediating+crosstalk+between+TGF-beta1+signaling+and+EGF+as+well+as+FGF+receptor+tyrosine+kinase-ERK+pathways+in+mesenchymal+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Sprouty2+downregulation+plays+a+pivotal+role+in+mediating+crosstalk+between+TGF-beta1+signaling+and+EGF+as+well+as+FGF+receptor+tyrosine+kinase-ERK+pathways+in+mesenchymal+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">41.
              </span><a name="pone.0001784-Manji1" id="pone.0001784-Manji1"></a>Manji HK, Gottesman II, Gould TD (2003) Signal transduction and genes-to-behaviors pathways in psychiatric diseases. Sci STKE  2003: pe49.  <ul class="find" data-citedArticleID="1073208" data-doi="10.1126/stke.2003.207.pe49"><li><a href="http://dx.doi.org/10.1126/stke.2003.207.pe49" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Signal+transduction+and+genes-to-behaviors+pathways+in+psychiatric+diseases." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Signal+transduction+and+genes-to-behaviors+pathways+in+psychiatric+diseases.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">42.
              </span><a name="pone.0001784-Winder1" id="pone.0001784-Winder1"></a>Winder DG, Sweatt JD (2001) Roles of serine/threonine phosphatases in hippocampal synaptic plasticity. Nat Rev Neurosci  2: 461–474.  <ul class="find" data-citedArticleID="1073260" data-doi="10.1038/35081514"><li><a href="http://dx.doi.org/10.1038/35081514" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Roles+of+serine%2Fthreonine+phosphatases+in+hippocampal+synaptic+plasticity." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Roles+of+serine%2Fthreonine+phosphatases+in+hippocampal+synaptic+plasticity.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">43.
              </span><a name="pone.0001784-Stefansson1" id="pone.0001784-Stefansson1"></a>Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, et al.  (2002) Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet.  71: 877–892.  <ul class="find" data-citedArticleID="1073238" data-doi="10.1086/342734"><li><a href="http://dx.doi.org/10.1086/342734" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Neuregulin+1+and+susceptibility+to+schizophrenia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Neuregulin+1+and+susceptibility+to+schizophrenia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">44.
              </span><a name="pone.0001784-Corfas1" id="pone.0001784-Corfas1"></a>Corfas G, Roy K, Buxbaum JD (2004) Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci  7: 575–580.  <ul class="find" data-citedArticleID="1073160" data-doi="10.1038/nn1258"><li><a href="http://dx.doi.org/10.1038/nn1258" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Neuregulin+1-erbB+signaling+and+the+molecular%2Fcellular+basis+of+schizophrenia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Neuregulin+1-erbB+signaling+and+the+molecular%2Fcellular+basis+of+schizophrenia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">45.
              </span><a name="pone.0001784-Hakak1" id="pone.0001784-Hakak1"></a>Hakak Y, Walker JR, Li C, Wong WH, Davis KL, et al.  (2001) Genome-wide expression analysis reveals dysregulation of myelination-relatedgenes in chronic schizophrenia. Proc Natl Acad Sci U S A  98: 4746–4751.  <ul class="find" data-citedArticleID="1073184" data-doi="10.1073/pnas.081071198"><li><a href="http://dx.doi.org/10.1073/pnas.081071198" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Genome-wide+expression+analysis+reveals+dysregulation+of+myelination-relatedgenes+in+chronic+schizophrenia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Genome-wide+expression+analysis+reveals+dysregulation+of+myelination-relatedgenes+in+chronic+schizophrenia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">46.
              </span><a name="pone.0001784-Michailov1" id="pone.0001784-Michailov1"></a>Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, et al.  (2004) Axonal neuregulin-1 regulates myelin sheath thickness. Science  304: 700–703.  <ul class="find" data-citedArticleID="1073214" data-doi="10.1126/science.1095862"><li><a href="http://dx.doi.org/10.1126/science.1095862" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Axonal+neuregulin-1+regulates+myelin+sheath+thickness." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Axonal+neuregulin-1+regulates+myelin+sheath+thickness.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">47.
              </span><a name="pone.0001784-Davis1" id="pone.0001784-Davis1"></a>Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, et al.  (2003) White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry  60: 443–456.  <ul class="find" data-citedArticleID="1073162" data-doi="10.1001/archpsyc.60.5.443"><li><a href="http://dx.doi.org/10.1001/archpsyc.60.5.443" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=White+matter+changes+in+schizophrenia%3A+evidence+for+myelin-related+dysfunction." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22White+matter+changes+in+schizophrenia%3A+evidence+for+myelin-related+dysfunction.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">48.
              </span><a name="pone.0001784-Futamura1" id="pone.0001784-Futamura1"></a>Futamura T, Toyooka K, Iritani S, Niizato K, Nakamura R, et al.  (2002) Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients. Mol Psychiatry  7: 673–682.  <ul class="find" data-citedArticleID="1073174" data-doi="10.1038/sj.mp.4001081"><li><a href="http://dx.doi.org/10.1038/sj.mp.4001081" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Abnormal+expression+of+epidermal+growth+factor+and+its+receptor+in+the+forebrain+and+serum+of+schizophrenic+patients." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Abnormal+expression+of+epidermal+growth+factor+and+its+receptor+in+the+forebrain+and+serum+of+schizophrenic+patients.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">49.
              </span><a name="pone.0001784-Hashimoto2" id="pone.0001784-Hashimoto2"></a>Hashimoto K, Shimizu E, Komatsu N, Watanabe H, Shinoda N, et al.  (2005) No changes in serum epidermal growth factor levels in patients with schizophrenia. Psychiatry Res  135: 257–260.  <ul class="find" data-citedArticleID="1073188" data-doi="10.1016/j.psychres.2003.11.006"><li><a href="http://dx.doi.org/10.1016/j.psychres.2003.11.006" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=No+changes+in+serum+epidermal+growth+factor+levels+in+patients+with+schizophrenia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22No+changes+in+serum+epidermal+growth+factor+levels+in+patients+with+schizophrenia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">50.
              </span><a name="pone.0001784-Hashimoto3" id="pone.0001784-Hashimoto3"></a>Hashimoto R, Numakawa T, Ohnishi T, Kumamaru E, Yagasaki Y, et al.  (2006) Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Hum Mol Genet  15: 3024–3033.  <ul class="find" data-citedArticleID="1073190" data-doi="10.1093/hmg/ddl244"><li><a href="http://dx.doi.org/10.1093/hmg/ddl244" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Impact+of+the+DISC1+Ser704Cys+polymorphism+on+risk+for+major+depression%2C+brain+morphology+and+ERK+signaling." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Impact+of+the+DISC1+Ser704Cys+polymorphism+on+risk+for+major+depression%2C+brain+morphology+and+ERK+signaling.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">51.
              </span><a name="pone.0001784-Schlessinger1" id="pone.0001784-Schlessinger1"></a>Schlessinger J (2000) Cell signaling by receptor tyrosine kinases. Cell  103: 211–225.  <ul class="find" data-citedArticleID="1073230" data-doi="10.1016/s0092-8674(00)00114-8"><li><a href="http://dx.doi.org/10.1016/s0092-8674(00)00114-8" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Cell+signaling+by+receptor+tyrosine+kinases." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Cell+signaling+by+receptor+tyrosine+kinases.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">52.
              </span><a name="pone.0001784-Sweatt1" id="pone.0001784-Sweatt1"></a>Sweatt JD (2004) Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol  14: 311–317.  <ul class="find" data-citedArticleID="1073240" data-doi="10.1016/j.conb.2004.04.001"><li><a href="http://dx.doi.org/10.1016/j.conb.2004.04.001" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mitogen-activated+protein+kinases+in+synaptic+plasticity+and+memory." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mitogen-activated+protein+kinases+in+synaptic+plasticity+and+memory.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">53.
              </span><a name="pone.0001784-Yusoff1" id="pone.0001784-Yusoff1"></a>Yusoff P, Lao DH, Ong SH, Wong ES, Lim J, et al.  (2002) Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf. J Biol Chem  277: 3195–3201.  <ul class="find" data-citedArticleID="1073270" data-doi="10.1074/jbc.m108368200"><li><a href="http://dx.doi.org/10.1074/jbc.m108368200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Sprouty2+inhibits+the+Ras%2FMAP+kinase+pathway+by+inhibiting+the+activation+of+Raf." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Sprouty2+inhibits+the+Ras%2FMAP+kinase+pathway+by+inhibiting+the+activation+of+Raf.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">54.
              </span><a name="pone.0001784-Tefft1" id="pone.0001784-Tefft1"></a>Tefft D, Lee M, Smith S, Crowe DL, Bellusci S, et al.  (2002) mSprouty2 inhibits FGF10-activated MAP kinase by differentially binding to upstream target proteins. Am J Physiol Lung Cell Mol Physiol.  283: L700–706.  <ul class="find" data-citedArticleID="1073246"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=mSprouty2+inhibits+FGF10-activated+MAP+kinase+by+differentially+binding+to+upstream+target+proteins.&amp;auth=&amp;atitle=mSprouty2+inhibits+FGF10-activated+MAP+kinase+by+differentially+binding+to+upstream+target+proteins." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=mSprouty2+inhibits+FGF10-activated+MAP+kinase+by+differentially+binding+to+upstream+target+proteins." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22mSprouty2+inhibits+FGF10-activated+MAP+kinase+by+differentially+binding+to+upstream+target+proteins.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">55.
              </span><a name="pone.0001784-Wong1" id="pone.0001784-Wong1"></a>Wong ES, Fong CW, Lim J, Yusoff P, Low BC, et al.  (2002) Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling. EMBO J  21: 4796–4808.  <ul class="find" data-citedArticleID="1073262" data-doi="10.1093/emboj/cdf493"><li><a href="http://dx.doi.org/10.1093/emboj/cdf493" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Sprouty2+attenuates+epidermal+growth+factor+receptor+ubiquitylation+and+endocytosis%2C+and+consequently+enhances+Ras%2FERK+signalling." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Sprouty2+attenuates+epidermal+growth+factor+receptor+ubiquitylation+and+endocytosis%2C+and+consequently+enhances+Ras%2FERK+signalling.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">56.
              </span><a name="pone.0001784-Kyosseva1" id="pone.0001784-Kyosseva1"></a>Kyosseva SV (2004) The role of the extracellular signal-regulated kinase pathway in cerebellar abnormalities in schizophrenia. Cerebellum  3: 94–99.  <ul class="find" data-citedArticleID="1073206" data-doi="10.1080/14734220410029164"><li><a href="http://dx.doi.org/10.1080/14734220410029164" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+role+of+the+extracellular+signal-regulated+kinase+pathway+in+cerebellar+abnormalities+in+schizophrenia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+role+of+the+extracellular+signal-regulated+kinase+pathway+in+cerebellar+abnormalities+in+schizophrenia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">57.
              </span><a name="pone.0001784-Browning1" id="pone.0001784-Browning1"></a>Browning JL, Patel T, Brandt PC, Young KA, Holcomb LA, et al.  (2005) Clozapine and the mitogen-activated protein kinase signal transduction pathway: implications for antipsychotic actions. Biol Psychiatry  57: 617–623.  <ul class="find" data-citedArticleID="1073148" data-doi="10.1016/j.biopsych.2004.12.002"><li><a href="http://dx.doi.org/10.1016/j.biopsych.2004.12.002" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Clozapine+and+the+mitogen-activated+protein+kinase+signal+transduction+pathway%3A+implications+for+antipsychotic+actions." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Clozapine+and+the+mitogen-activated+protein+kinase+signal+transduction+pathway%3A+implications+for+antipsychotic+actions.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">58.
              </span><a name="pone.0001784-Yang1" id="pone.0001784-Yang1"></a>Yang BH, Son H, Kim SH, Nam JH, Choi JH, et al.  (2004) Phosphorylation of ERK and CREB in cultured hippocampal neurons after haloperidol and risperidone administration. Psychiatry Clin Neurosci  58: 262–267.  <ul class="find" data-citedArticleID="1073268" data-doi="10.1111/j.1440-1819.2004.01229.x"><li><a href="http://dx.doi.org/10.1111/j.1440-1819.2004.01229.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Phosphorylation+of+ERK+and+CREB+in+cultured+hippocampal+neurons+after+haloperidol+and+risperidone+administration." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Phosphorylation+of+ERK+and+CREB+in+cultured+hippocampal+neurons+after+haloperidol+and+risperidone+administration.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">59.
              </span><a name="pone.0001784-Pozzi1" id="pone.0001784-Pozzi1"></a>Pozzi L, Håkansson K, Usiello A, Borgkvist A, Lindskog M, et al.  (2003) Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum. J Neurochem  86: 451–459.  <ul class="find" data-citedArticleID="1073224" data-doi="10.1046/j.1471-4159.2003.01851.x"><li><a href="http://dx.doi.org/10.1046/j.1471-4159.2003.01851.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Opposite+regulation+by+typical+and+atypical+anti-psychotics+of+ERK1%2F2%2C+CREB+and+Elk-1+phosphorylation+in+mouse+dorsal+striatum." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Opposite+regulation+by+typical+and+atypical+anti-psychotics+of+ERK1%2F2%2C+CREB+and+Elk-1+phosphorylation+in+mouse+dorsal+striatum.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">60.
              </span><a name="pone.0001784-Torrey1" id="pone.0001784-Torrey1"></a>Torrey EF, Mortensen PB, Pedersen CB, Wohlfahrt J, Melbye M (2001) Risk factors and confounders in the geographical clustering of schizophrenia. Schizophr Res  49: 295–299.  <ul class="find" data-citedArticleID="1073252" data-doi="10.1016/s0920-9964(00)00081-5"><li><a href="http://dx.doi.org/10.1016/s0920-9964(00)00081-5" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Risk+factors+and+confounders+in+the+geographical+clustering+of+schizophrenia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Risk+factors+and+confounders+in+the+geographical+clustering+of+schizophrenia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">61.
              </span><a name="pone.0001784-Didriksen1" id="pone.0001784-Didriksen1"></a>Didriksen M (1995) Effects of antipsychotics on cognitive behavior in rats using the delayed non-match to position paradigm. Eur J Pharmacol  28: 241–250.  <ul class="find" data-citedArticleID="1073166" data-doi="10.1016/0014-2999(95)00242-d"><li><a href="http://dx.doi.org/10.1016/0014-2999(95)00242-d" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Effects+of+antipsychotics+on+cognitive+behavior+in+rats+using+the+delayed+non-match+to+position+paradigm." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Effects+of+antipsychotics+on+cognitive+behavior+in+rats+using+the+delayed+non-match+to+position+paradigm.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">62.
              </span><a name="pone.0001784-Bymaster1" id="pone.0001784-Bymaster1"></a>Bymaster FP, Hemrick-Luecke SK, Perry KW, Fuller RW (1996) Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, a1-adrenergic and muscarinic receptors in vivo in rats. Psychopharmacology (Berl.)  124: 87–94.  <ul class="find" data-citedArticleID="1073156" data-doi="10.1007/bf02245608"><li><a href="http://dx.doi.org/10.1007/bf02245608" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Neurochemical+evidence+for+antagonism+by+olanzapine+of+dopamine%2C+serotonin%2C+a1-adrenergic+and+muscarinic+receptors+in+vivo+in+rats." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Neurochemical+evidence+for+antagonism+by+olanzapine+of+dopamine%2C+serotonin%2C+a1-adrenergic+and+muscarinic+receptors+in+vivo+in+rats.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">63.
              </span><a name="pone.0001784-Skarsfeldt1" id="pone.0001784-Skarsfeldt1"></a>Skarsfeldt T (1996) Differential effect of antipsychotics on place navigation of rats in Morris water maze. A comparative study between novel and reference antipsychotics. Psychopharmacology (Berl.)  124: 126–133.  <ul class="find" data-citedArticleID="1073236" data-doi="10.1007/bf02245612"><li><a href="http://dx.doi.org/10.1007/bf02245612" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Differential+effect+of+antipsychotics+on+place+navigation+of+rats+in+Morris+water+maze.+A+comparative+study+between+novel+and+reference+antipsychotics." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Differential+effect+of+antipsychotics+on+place+navigation+of+rats+in+Morris+water+maze.+A+comparative+study+between+novel+and+reference+antipsychotics.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">64.
              </span><a name="pone.0001784-Kinon1" id="pone.0001784-Kinon1"></a>Kinon BJ, Lieberman JA (1996) Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology (Berl)  124: 2–34.  <ul class="find" data-citedArticleID="1073202" data-doi="10.1007/bf02245602"><li><a href="http://dx.doi.org/10.1007/bf02245602" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mechanisms+of+action+of+atypical+antipsychotic+drugs%3A+a+critical+analysis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mechanisms+of+action+of+atypical+antipsychotic+drugs%3A+a+critical+analysis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">65.
              </span><a name="pone.0001784-Terry1" id="pone.0001784-Terry1"></a>Terry AV Jr, Hill WD, Parikh V, Waller JL, Evans DR, et al.  (2003) Differential effects of haloperidol, risperidone, and clozapine exposure on cholinergic markers and spatial learning performance in rats. Neuropsychopharmacology  28: 300–309.  <ul class="find" data-citedArticleID="1073248" data-doi="10.1038/sj.npp.1300039"><li><a href="http://dx.doi.org/10.1038/sj.npp.1300039" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Differential+effects+of+haloperidol%2C+risperidone%2C+and+clozapine+exposure+on+cholinergic+markers+and+spatial+learning+performance+in+rats." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Differential+effects+of+haloperidol%2C+risperidone%2C+and+clozapine+exposure+on+cholinergic+markers+and+spatial+learning+performance+in+rats.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">66.
              </span><a name="pone.0001784-Terry2" id="pone.0001784-Terry2"></a>Terry AV Jr, Hill WD, Parikh V, Evans DR, Waller JL, et al.  (2002) Differential effects of chronic haloperidol and olanzapine exposure on brain cholinergic markers and spatial learning in rats. Psychopharmacology (Berl)  164: 360–368.  <ul class="find" data-citedArticleID="1073250" data-doi="10.1007/s00213-002-1230-z"><li><a href="http://dx.doi.org/10.1007/s00213-002-1230-z" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Differential+effects+of+chronic+haloperidol+and+olanzapine+exposure+on+brain+cholinergic+markers+and+spatial+learning+in+rats." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Differential+effects+of+chronic+haloperidol+and+olanzapine+exposure+on+brain+cholinergic+markers+and+spatial+learning+in+rats.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.XML" value="120143"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.PDF" value="166713"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t001.PNG_L" value="201158"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t001.PNG_M" value="129452"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t001.PNG_S" value="14300"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t001.TIF" value="920808"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t001.PNG_I" value="40013"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t002.PNG_L" value="79463"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t002.PNG_M" value="45373"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t002.PNG_S" value="8571"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t002.TIF" value="392060"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t002.PNG_I" value="13509"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.g001.PNG_L" value="49156"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.g001.PNG_M" value="16786"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.g001.PNG_S" value="2500"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.g001.TIF" value="106610"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.g001.PNG_I" value="7203"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t003.PNG_L" value="34449"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t003.PNG_M" value="43095"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t003.PNG_S" value="9426"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t003.TIF" value="179978"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t003.PNG_I" value="13924"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.g002.PNG_L" value="34807"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.g002.PNG_M" value="15152"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.g002.PNG_S" value="2397"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.g002.TIF" value="85134"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.g002.PNG_I" value="6738"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.g003.PNG_L" value="110911"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.g003.PNG_M" value="23777"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.g003.PNG_S" value="4442"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.g003.TIF" value="233762"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.g003.PNG_I" value="21616"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t004.PNG_L" value="116462"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t004.PNG_M" value="67288"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t004.PNG_S" value="9960"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t004.TIF" value="579238"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t004.PNG_I" value="20455"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t005.PNG_L" value="85516"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t005.PNG_M" value="54982"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t005.PNG_S" value="8775"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t005.TIF" value="384160"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001784.t005.PNG_I" value="16983"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001784&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001784" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001784&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0001784&volume=&issue=&title=Decreased Expression of Sprouty2 in the Dorsolateral Prefrontal Cortex in Schizophrenia and Bipolar Disorder: A Correlation with BDNF Expression&author_name=Anilkumar%20Pillai&start_page=1&end_page=8" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001784" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001784" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0001784" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001784&amp;t=Decreased%20Expression%20of%20Sprouty2%20in%20the%20Dorsolateral%20Prefrontal%20Cortex%20in%20Schizophrenia%20and%20Bipolar%20Disorder%3A%20A%20Correlation%20with%20BDNF%20Expression" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001784&title=Decreased%20Expression%20of%20Sprouty2%20in%20the%20Dorsolateral%20Prefrontal%20Cortex%20in%20Schizophrenia%20and%20Bipolar%20Disorder%3A%20A%20Correlation%20with%20BDNF%20Expression&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001784&amp;title=Decreased%20Expression%20of%20Sprouty2%20in%20the%20Dorsolateral%20Prefrontal%20Cortex%20in%20Schizophrenia%20and%20Bipolar%20Disorder%3A%20A%20Correlation%20with%20BDNF%20Expression" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001784" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0001784&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'Decreased Expression of Sprouty2 in the Dorsolateral Prefrontal Cortex in Schizophrenia and Bipolar Disorder: A Correlation with BDNF Expression';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0001784';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20Decreased%20Expression%20of%20Sprouty2%20in%20the%20Dorsolateral%20Prefrontal%20Cortex%20in%20Schizophrenia%20and%20Bipolar%20Disorder%3A%20A%20Correlation%20with%20BDNF%20Expression http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001784" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0001784" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">











          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Antipsychotics%22" title="Search for articles in the subject area:'Antipsychotics'"><div class="flagText">Antipsychotics</div></a>
              <div data-categoryid="25897" data-articleid="26392"
                   data-categoryname="Antipsychotics"
                   class="flagImage" title="Flag 'Antipsychotics' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Bipolar+disorder%22" title="Search for articles in the subject area:'Bipolar disorder'"><div class="flagText">Bipolar disorder</div></a>
              <div data-categoryid="24913" data-articleid="26392"
                   data-categoryname="Bipolar disorder"
                   class="flagImage" title="Flag 'Bipolar disorder' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Drug+therapy%22" title="Search for articles in the subject area:'Drug therapy'"><div class="flagText">Drug therapy</div></a>
              <div data-categoryid="18461" data-articleid="26392"
                   data-categoryname="Drug therapy"
                   class="flagImage" title="Flag 'Drug therapy' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22ERK+signaling+cascade%22" title="Search for articles in the subject area:'ERK signaling cascade'"><div class="flagText">ERK signaling cascade</div></a>
              <div data-categoryid="19801" data-articleid="26392"
                   data-categoryname="ERK signaling cascade"
                   class="flagImage" title="Flag 'ERK signaling cascade' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Frontal+lobe%22" title="Search for articles in the subject area:'Frontal lobe'"><div class="flagText">Frontal lobe</div></a>
              <div data-categoryid="48681" data-articleid="26392"
                   data-categoryname="Frontal lobe"
                   class="flagImage" title="Flag 'Frontal lobe' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Growth+factors%22" title="Search for articles in the subject area:'Growth factors'"><div class="flagText">Growth factors</div></a>
              <div data-categoryid="35097" data-articleid="26392"
                   data-categoryname="Growth factors"
                   class="flagImage" title="Flag 'Growth factors' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22MAPK+signaling+cascades%22" title="Search for articles in the subject area:'MAPK signaling cascades'"><div class="flagText">MAPK signaling cascades</div></a>
              <div data-categoryid="21105" data-articleid="26392"
                   data-categoryname="MAPK signaling cascades"
                   class="flagImage" title="Flag 'MAPK signaling cascades' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Schizophrenia%22" title="Search for articles in the subject area:'Schizophrenia'"><div class="flagText">Schizophrenia</div></a>
              <div data-categoryid="18371" data-articleid="26392"
                   data-categoryname="Schizophrenia"
                   class="flagImage" title="Flag 'Schizophrenia' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=3836'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=9783'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=2384&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>

<div class="block sidebar-comments">
    <div class="header">
        <h3>Comments</h3>
    </div>
      <p><a href="/annotation/listThread.action?root=705">Referee comments: Referee 2</a><br>Posted by PLoS_ONE_Group</p>
      <p><a href="/annotation/listThread.action?root=2995">Referee comments: Referee 1</a><br>Posted by PLoS_ONE_Group</p>
</div>

</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
